Skip to Main Content
CWRU Links

2014

2014 Member Publications

This is a list of publications authored by Cancer Center members. Cancer Center members are highlighted in BOLD text. 

Publications are listed in alphabetical order by first author. 

Abboud SE, Wolansky LJ, Manjila SV, Lo SS, Arafah BM, Selman WR, Couce ME, Rogers LR. Histologically Proven Radiation-Induced Brainstem Glioma 93 Months After External Beam Radiotherapy for Pituitary Macroadenoma: Radiation Treatment Dose and Volume Correlation. J Neuroimaging. 2014. in press

Abelson B, Reddy CA, Ciezki JP, Angermeier K, Ulchaker J, Klein EA, Wood HM. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy. Urology. 2014 Feb;83(2):422-7.

Abraham J, Nunez-Allvarez Y, Hettmer S, Carrií E, Chen HI, Nishijo K, Huang ET, Prajapati SI, Walker RL, Davis S, Rebeles J, Wiebush H, McCleish AT, Hampton ST, Bjornson CR, Brack AS, Wagers AJ, Rando TA, Capecchi MR, Marini FC, Ehler BR, Zarzabal LA, Zarzabal LA, Goros MW, Michalek JE, Meltzer P, Langenau DM, LeGallo RD, Mansoor A, Chen Y, Suelves M, Rubin BP, Keller C Lineage of origin in rhabdomyosarcoma informs pharmacological response. Genes Dev. 2014 Jul 15;28(14):1578-91. doi: 10.1101/gad.238733.114.

Abraham J. Introduction and commentary: Paving the way for biosimilars in oncology, part 3: Clinical and economic impact of oncology biosimilars. Semin Oncol. 2014 Apr;41 Suppl 3:S1-2. doi: 10.1053/j.seminoncol.2014.03.010. Epub 2014 Mar 14. No abstract available.

Abraham J. PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies? Expert Rev Anticancer Ther. 2014.11:1-18.

Abrams JA, Appelman HD, Beer DG, Berry LD, Chak A, Falk GW, Fitzgerald RC, Ginsberg GG, Grady WM, Joshi BP, Lynch JP, Markowitz S, Richmond ES, Rustgi AK, Seibel EJ, Shaheen NJ, Shyr Y, Umar A, Wang KK, Wang TC, Wang TD, Yassin R. Barrett's Esophagus Translational Research Network (BETRNet): The Pivotal Role of Multi-institutional Collaboration in Esophageal Adenocarcinoma Research. Gastroenterology. 2014 Jun;146(7):1586-90. doi: 10.1053/j.gastro.2014.04.014. Epub 2014 Apr 21. No abstract available.

Abrams JA, Chak A. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma. J Natl Cancer Inst. 2014. In press

Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD, Triozzi PL. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol. 2014 Apr;58(2):182-6.

Adhikari P, Wen AM, French RH, Parsegian VA, Steinmetz NF, Podgornik R, Ching WY. Electronic structure, dielectric response, and surface charge distribution of RGD (1FUV) peptide. Sci Rep. 2014 Jul 8;4:5605. doi: 10.1038/srep05605.

Advani AS, Mahfouz RZ, Maciejewski J, Rybicki L, Sekeres M, Tripp B, Kalaycio M, Bates J, Saunthararajah Y. Ribosomal S6 kinase and AKT phosphorylation as pharmacodynamic biomarkers in patients with myelodysplastic syndrome treated with RAD001. Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):172-177.e1. doi: 10.1016/j.clml.2013.10.001. Epub 2013 Nov 11.

Advani AS, McDonough S, Copelan E, Willman C, Mulford DA, List AF, Sekeres MA, Othus M, Appelbaum FR. SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia. Br J Haematol. 2014. 167:233-7.

Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia. Br J Haematol. 2014 May;165(4):504-9. doi: 10.1111/bjh.12778. Epub 2014 Mar 3.

Agner SC, Rosen MA, Englander S, Tomaszewski JE, Feldman MD, Zhang P, Mies C, Schnall MD, Madabhushi A. Computerized Image Analysis for Identifying Triple-Negative Breast Cancers and Differentiating Them from Other Molecular Subtypes of Breast Cancer on Dynamic Contrast-enhanced MR Images: A Feasibility Study. Radiology. 2014 Mar 10:121031. [Epub ahead of print]

Agwa ES, Ma PC. Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib. Cancer Manag Res. 2014. 6:397-404.

Ahmed Q, Hussein Y, Hayek K, Bandyopadhyay S, Semaan A, Abdul-Karim F, Al-Wahab Z, Munkarah AR, Elshaikh MA, Alosh B, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R. Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis. Gynecol Oncol. 2014. 132:372-6.

Ai J, Advani A. Current status of antibody therapy in ALL. Br J Haematol. 2014. in press

Ai J, Stevenson JP. Current Issues in Malignant Pleural Mesothelioma Evaluation and Management. Oncologist. 2014 Sep;19(9):975-984. Epub 2014 Jul 24. Review.

Al-Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Adelstein DJ, Koyfman SA. Solitary dural metastasis at presentation in a patient with untreated human papillomavirus-associated squamous cell carcinoma of the oropharynx. Head Neck. 2014. 36:E103-5.

Alashkar B, Faulx AL, Hepner A, Pulice R, Vemana S, Greer KB, Isenberg GA, Falck-Ytter Y, Chak A. Development of a program to train physician extenders to perform transnasal esophagoscopy and screen for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 May;12(5):785-92. doi: 10.1016/j.cgh.2013.10.014. Epub 2013 Oct 23.

Alexander RE, Montironi R, Lopez-Beltran A, Williamson SR, Wang M, Post KM, Sen JD, Arnold AK, Zhang S, Wang X, Koch MO, Hahn NM, Masterson TA, Maclennan GT, Davidson DD, Compérat E, Cheng L. EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder. Mod Pathol. 2014 Jan;27(1):107-12.

Ali S, Palmer FL, Yu C, Dilorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands. Ann Surg Oncol. 2014 In press

Alimohamed N, Lee JL, Srinivas S, Bjarnason GA, Knox JJ, Mackenzie MJ, Wood L, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Tantravahi S, Kollmannsberger C, North S, Rini BI, Choueiri TK, Heng DY. A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma. Clin Genitourin Cancer.2014. In press

Alkabbani AG, Mon SY, Hatipoglu B, Kennedy L, Faiman C, Weil RJ, Hamrahian AH. Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth? Pituitary. 2014. 17:97-102

Amick J, Schlanger SE, Wachnowsky C, Moseng MA, Emerson CC, Dare M, Luo WI, Ithychanda SS, Nix JC, Cowan JA, Page RC, Misra S. Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone. Protein Sci. 2014 Jun;23(6):833-42. doi: 10.1002/pro.2466. Epub 2014 Apr 17.

Anand S, Rollakanti KR, Horst RL, Hasan T, Maytin EV. Combination of Oral Vitamin D(3) with Photodynamic Therapy Enhances Tumor Cell Death in a Murine Model of Cutaneous Squamous Cell Carcinoma. Photochem Photobiol. 2014 May 7. doi: 10.1111/php.12286. [Epub ahead of print]

Andersen T, Markussen C, Dornish M, Heier-Baardson H, Melvik JE, Alsberg E, Christensen BE. In situ gelation for cell immobilization and culture in alginate foam scaffolds. Tissue Eng Part A. 2014 In press

Andersen T, Melvik JE, Gåserød O, Alsberg E, Christensen BE. Ionically gelled alginate foams: Physical properties controlled by type, amount and source of gelling ions.. Carbohydr Polym. 2014 Jan;99:249-56

Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S; Gliogene Consortium, Bondy ML, Melin BS. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014. 16:1333-40

Aplenc R, Zhang MJ, Sung L, Zhu X, Ho VT, Cooke K, Dvorak C, Hale G, Isola LM, Lazarus HM, McCarthy PL, Olsson R, Pulsipher M, Pasquini MC, Bunin N; Regimen-Related Toxicity Working Committee, Center for International Blood and Marrow Transplant Research. Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Blood. 2014 May 29;123(22):3504-11. doi: 10.1182/blood-2013-03-490334. Epub 2014 Apr 7.

Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014 Jun 5;123(23):3664-71. doi: 10.1182/blood-2014-01-552984. Epub 2014 Apr 17.

Askar M, Sun Y, Rybicki L, Zhang A, Thomas D, Kalaycio M, Pohlman B, Dean R, Duong H, Hanna R, Maciejewski J, Majhail NS, Bolwell B, Sobecks R. Synergistic Effect of Major Histocompatibility Complex Class I-Related Chain A and Human Leukocyte Antigen-DPB1 Mismatches in Association with Acute Graft-versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2014. 11:1835-40.

Augestad KM, Norum J, Rose J, Lindsetmo RO. A prospective analysis of false positive events in a National Colon Cancer Surveillance Program. BMC Health Serv Res. 2014 Mar 27;14:137. doi: 10.1186/1472-6963-14-137.

Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther. 2014. 13:2288-302.

Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death Dis. 2014. In Press

Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, et al. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia. 2014 Mar;28(3):658-65. doi: 10.1038/leu.2013.253. Epub 2013 Aug 30.

Bachir AI, Zareno J, Moissoglu K, Plow EF, Gratton E, Horwitz AR. Integrin-associated complexes form hierarchically with variable stoichiometry in nascent adhesions. Curr Biol. 2014 Aug 18;24(16):1845-53. doi: 10.1016/j.cub.2014.07.011. Epub 2014 Jul 31.

Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H, Lewis L, Tombrello J, Tsavachidis S, Liu Y, Jalali A, Plon SE, Lau CC, Parsons DW, Claus EB, Barnholtz-Sloan J, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Walsh KM, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Thompson PA, Muzny DM, Gibbs RA, Melin BS, Bondy ML; Gliogene Consortium. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2014. In Press

Bakirtzi K, West G, Fiocchi C, Man Law IK, Iliopoulos D, Pothoulakis C. The Neurotensin-HIF-1ë±-VEGFë± Axis Orchestrates Hypoxia, Colonic Inflammation, and Intestinal Angiogenesis. Am J Pathol. 2014 in press

Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre CF, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS. Hospital Length of Stay in the First 100åÊDays after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources. Biol Blood Marrow Transplant. 2014. 11:1819-27.

Barginear MF, Muss H, Kimmick G, Owusu C, Mrozek E, Shahrokni A, Ballman K, Hurria A. Breast cancer and aging: results of the U13 conference breast cancer panel. Breast Cancer Res Treat. 2014. 146:1-6.

Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, Wootton T, Rumble RB, Dusetzina SB, Virgo KS. Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol. 2014 Sep 8. doi:pii: JCO.2013.54.8404. [Epub ahead of print]

Basch E, Snyder C, McNiff K, Brown R, Maddux S, Smith ML, Atkinson TM, Howell D, Chiang A, Wood W, Levitan N, Wu AW, Krzyzanowska M. Patient-reported outcome performance measures in oncology. J Oncol Pract. 2014 May;10(3):209-11. doi: 10.1200/JOP.2014.001423. Epub 2014 Apr 22. No abstract available.

Bayliss EA, Balasubramianian BA, Gill JM, Stange KC. Perspectives in primary care: implementing patient-centered care coordination for individuals with multiple chronic medical conditions. Ann Fam Med. 2014. 12:500-3.

Bayliss EA, Bonds DE, Boyd CM, Davis MM, Finke B, Fox MH, Glasgow RE, Goodman RA, Heurtin-Roberts S, Lachenmayr S, Lind C, Madigan EA, Meyers DS, Mintz S, Nilsen WJ, Okun S, Ruiz S, Salive ME, Stange KC. Understanding the context of health for persons with multiple chronic conditions: moving from what is the matter to what matters. Ann Fam Med. 2014 May-Jun;12(3):260-9. doi: 10.1370/afm.1643.

Bedogni B. Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting. Pigment Cell Melanoma Res. 2014 In press

Berdis AJ. Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer. Expert Opin Drug Discov. 2014 Feb;9(2):167-81.

Berger NA. Obesity and cancer pathogenesis. Ann N Y Acad Sci. 2014 Apr;1311:57-76. doi: 10.1111/nyas.12416.

Berger NA. Obesity-associated gastrointestinal tract cancer: from beginning to end. Cancer. 2014 Apr 1;120(7):935-9. doi: 10.1002/cncr.28534. Epub 2014 Jan 21. No abstract available.

Bernhofer EI, Higgins PA, Daly BJ, Burant CJ, Hornick TR. Hospital lighting and its association with sleep, mood and pain in medical inpatients. J Adv Nurs. 2014 In press.

Berry DC, Levi L, Noy N. Holo-Retinol-Binding Protein and Its Receptor STRA6 Drive Oncogenic Transformation. Cancer Res. 2014. 74:6341-51.

Bhaskaran S, Abu-Arja RF, Abusin G, Cabral L, Nagle K, Ahuja S, Egler R, Cooke KR, Lazarus HM. Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014. in press

Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: Report from the Children's Oncology Group. J Clin Oncol. 2014 Jan 6.  In press

Biswas T, Sharma N, Machtay M. Controversies in the management of stage III non-small-cell lung cancer. Expert Rev Anticancer Ther. 2014 Mar;14(3):333-47. doi: 10.1586/14737140.2014.867809. Epub 2014 Jan 8.

Bock C, Jarczok MN, Litaker D. Community-based efforts to promote physical activity: a systematic review of interventions considering mode of delivery, study quality and population subgroups. J Sci Med Sport. 2014 May;17(3):276-82. doi: 10.1016/j.jsams.2013.04.009. Epub 2013 May 19.

Bohon J, D'Mello R, Ralston C, Gupta S, Chance MR. Synchrotron X-ray footprinting on tour. J Synchrotron Radiat. 2014 Jan 1;21(Pt 1):24-31. PMCID: PMC3874017

Boyd-Tressler A, Penuela S, Laird DW, Dubyak GR. Chemotherapeutic Drugs Induce ATP Release via Caspase-gated Pannexin-1 Channels and a Caspase/Pannexin-1-independent Mechanism. J Biol Chem. 2014. 289:27246-63.

Brett-Morris A, Wright BM, Seo Y, Pasupuleti V, Zhang J, Lu J, Spina R, Bar EE, Gujrati M, Schur R, Lu ZR, Welford SM. The Polyamine Catabolic Enzyme SAT1 Modulates Tumorigenesis and Radiation Response in GBM. Cancer Res. 2014. 746925-34.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco Jr FJ, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2014. pii: S0302-2838(14)00956-7.

Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK. ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035. Epub 2014 Feb 25.

Brubaker D, Difeo A, Chen Y, Pearl T, Zhai K, Bebek G, Chance M, Barnholtz-Sloan J. Drug intervention response predictions with paradigm (dirpp) identifies drug resistant cancer cell lines and pathway mechanisms of resistance. Pac Symp Biocomput. 2014;19:125-35.

Bruckman MA, Randolph LN, Vanmeter A, Hern S, Shoffstall AJ, Taurog RE, Steinmetz NF. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology. 2014 Jan 20;449:163-73.

Bruckman MA, Steinmetz NF. Chemical modification of the inner and outer surfaces of Tobacco Mosaic Virus (TMV). Methods Mol Biol. 2014;1108:173-85.

Bussières-Marmen S, Hutchins AP, Schirbel A, Rebert N, Tiganis T, Fiocchi C, Miranda-Saavedra D, Tremblay ML. Characterization of PTPN2 and its use as a biomarker. Methods. 2014 Jan 15;65(2):239-46.

Butchi NB, Hinton DR, Stohlman SA, Kapil P, Fensterl V, Sen GC, Bergmann CC. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages. J Virol. 2014 Jan;88(2):1051-64.

Campbell C, Grapov D, Fiehn O, Chandler CJ, Burnett DJ, Souza EC, Casazza GA, Gustafson MB, Keim NL, Newman JW, Hunter GR, Fernandez JR, Garvey WT, Harper ME, Hoppel CL, Meissen JK, Take K, Adams SH. Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin. PLoS One. 2014 Jan 8;9(1):e84260.

Carter RR, Difeo A, Bogie K, Zhang GQ, Sun J. Crowdsourcing awareness: Exploration of the ovarian cancer knowledge gap through Amazon Mechanical Turk. PLoS One. 2014 Jan 22;9(1):e85508.  PMCID: PMC3899016

Ceppi P, Hadji A, Kohlhapp FJ, Pattanayak A, Hau A, Liu X, Liu H, Murmann AE, Peter ME. CD95 and CD95L promote and protect cancer stem cells. Nat Commun. 2014. 5:5238.

Chak A, Alashkar BM, Isenberg GA, Chandar AK, Greer KB, Hepner A, Pulice RD, Vemana S, Falck-Ytter Y, Faulx AL. Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans. Gastrointest Endosc. 2014. 80:774-82.

Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ; Cancer Prevention Network. Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett's Esophagus. Clin Gastroenterol Hepatol. 2014 Sep 15. doi:pii: S1542-3565(14)01317-2

Chang A, Datta-Barua I, McLaughlin B, Daly B. A survey of prognosis discussions held by health-care providers who request palliative care consultation. Palliat Med. 2014 In press

Chang JE, Li H, Smith MR, Gascoyne RD, Paietta EM, Yang DT, Advani RH, Horning SJ, Kahl BS. Phase II study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group Study (E1405). Blood. 2014 Jan 23 In press.

Chang KH, Ercole CE, Sharifi N. Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences. Br J Cancer. 2014. 111:1249-54.

Chang MJ, Zhong F, Lavik AR, Parys JB, Berridge MJ, Distelhorst CW. Feedback regulation mediated by Bcl-2 and DARPP-32 regulates inositol 1,4,5-trisphosphate receptor phosphorylation and promotes cell survival. Proc Natl Acad Sci U S A. 2014 Jan 6. In press

Chao ST, Meier T, Hugebeck B, Reddy CA, Godley A, Kolar M, Suh JH. Workflow Enhancement (WE) Improves Safety in Radiation Oncology: Putting the WE and Team Together. Int J Radiat Oncol Biol Phys. 2014 Mar 28. doi:pii: S0360-3016(14)00099-6.  10.1016/j.ijrobp.2014.01.024. [Epub ahead of print]

Chase SM, Crabtree BF, Stewart EE, Nutting PA, Miller WL, Stange KC, Jaaon CR. Coaching strategies for enhancing practice transformation. Fam Pract. 2014. in press

Chattopadhyay S, Kessler SP, Colucci JA, Yamashita M, Senanayake Pd, Sen GC. Tissue-specific expression of transgenic secreted ACE in vasculature can restore normal kidney functions, but not blood pressure, of Ace-/- mice. PLoS One. 2014 Jan 27;9(1):e87484.

Chaturvedi S, Garcia JA. Novel agents in the management of castration resistant prostate cancer. J Carcinog. 2014;13:5. Review.

Chaturvedi S, McCrae KR. Recent advances in the antiphospholipid antibody syndrome. Curr Opin Hematol. 2014 Sep;21(5):371-9. doi: 10.1097/MOH.0000000000000067.

Chaturvedi S, Sidana S, Elson P, Khorana AA, McCrae KR. Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer. PLoS One. 2014 Aug 15;9(8):e94048

Chee CE, Meropol NJ. Current Status of Gene Expression Profiling to Assist Decision Making in Stage II Colon Cancer. Oncologist. 2014 May 28. doi:pii: theoncologist.2013-0471. [Epub ahead of print] Review.

Chen DJ, Falzarano SM, McKenney JK, Przybycin CG, Reynolds JP, Roma A, Jones JS, Stephenson A, Klein E, Magi-Galluzzi C. Does cumulative prostate cancer length in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance? BJU Int. 2014 Jul 25. doi: 10.1111/bju.12880. [Epub ahead of print]

Cheng CW, Solorio LD, Alsberg E. Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol Adv. 2014 Jan 10 In press

Cheng Y, Doane TL, Chuang CH, Ziady A, Burda C. Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy. Small. 2014 Feb 10. In press

Cheon H, Borden EC, Stark GR. Interferons and their stimulated genes in the tumor microenvironment. Semin Oncol. 2014 Apr;41(2):156-73. doi: 10.1053/j.seminoncol.2014.02.002. Epub 2014 Feb 14. Review.

Chevli KK, Duff M, Walter P, Yu C, Capuder B, Elshafei A, Malczewski S, Kattan MW, Jones JS. Urinary PCA3 as a predictor for prostate cancer in a cohort of 3073 men undergoing initial prostate biopsy. J Urol. 2014. In press

Cho CF, Shukla S, Simpson EJ, Steinmetz NF, Luyt LG, Lewis JD. Molecular targeted viral nanoparticles as tools for imaging cancer. Methods Mol Biol. 2014;1108:211-30.

Choi H, Mazzone P. Radon and lung cancer: Assessing and mitigating the risk. Cleve Clin J Med. 2014 Sep;81(9):567-575. Review.

Choi SH, Kim BG, Robinson J, Fink S, Yan M, Sporn MB, Markowitz SD, Letterio JJ. Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. J Clin Invest. 2014 Jun 2;124(6):2472-82.

Chopra K, Folstein MK, Manson PN, Gastman BR. Complex craniofacial reconstruction using stereolithographic modeling. Ann Plast Surg. 2014 Jan;72(1):59-63.

Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2015. 1219:1-9.

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM Jr, Blanke CD, Klein EA. Age-Related Cataract in Men in the Selenium and Vitamin E Cancer Prevention Trial Eye Endpoints Study: A Randomized Clinical Trial. JAMA Ophthalmol. 2014 in press

Cipriano R, Bryson BL, Miskimen KL, Bartel CA, Hernandez-Sanchez W, Bruntz RC, Scott SA, Lindsley CW, Brown HA, Jackson MW. Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B. Oncogene. 2014 Jun 19;33(25):3298-306. doi: 10.1038/onc.2013.293. Epub 2013 Aug 5.

Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Mol Cancer Res. 2014. 12:1156-65. PMCID 4135001

Colen R, Foster I, Gatenby R, Giger ME, Gillies R, Gutman D, Heller M, Jain R, Madabhushi A, Madhavan S, Napel S, Rao A, Saltz J, Tatum J, Verhaak R, Whitman G. NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures. Transl Oncol. 2014. 7:556-69.

Collie AM, Hill BT, Stevens GH, Fenner K, Gazdick E, Hsi ED. Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy. Am J Clin Pathol. 2014 Apr;141(4):515-21. doi: 10.1309/AJCP8IB8FRQDVPXL.

Cooper DA, Jha BK, Silverman RH, Hesselberth JR, Barton DJ. Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAs. Nucleic Acids Res. 2014 Feb 5. In press

Cooper GS, Xu F, Schluchter MD, Koroukian SM, Barnholtz Sloan JS. Diverticulosis and the risk of interval colorectal cancer. Dig Dis Sci. 2014. 59:2765-72.

Corradin O, Saiakhova A, Akhtar-Zaidi B, Myeroff L, Willis J, Cowper-Sal-Lari R, Lupien M, Markowitz S, Scacheri PC. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 2014 Jan;24(1):1-13.

Craig SE, Brady-Kalnay SM. Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis. Semin Cell Dev Biol. 2014 Sep 16. doi:pii: S1084-9521(14)00259-6.

Cui L, Carter R, Zhang GQ. Evaluation of a novel conjunctive exploratory navigation interface for consumer health information: a crowdsourced comparative study. J Med Internet Res. 2014 Feb 10;16(2):e45.

Dabir S, Babakoohi S, Kluge A, Morrow JJ, Kresak A, Yang M, MacPherson D, Wildey G, Dowlati A. RET Mutation and Expression in Small-Cell Lung Cancer. J Thorac Oncol. 2014 Sep;9(9):1316-23. doi: 10.1097/JTO.0000000000000234.

Dabir S, Kluge A, Kresak A, Yang M, Fu P, Groner B, Wildey G, Dowlati A. Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival. Clin Cancer Res. 2014 Aug 14. [Epub ahead of print]

Dabir S, Kluge A, McColl K, Liu Y, Lam M, Halmos B, Wildey G, Dowlati A. PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status. Int J Cancer. 2014 Mar 1;134(5):1045-54.

Daly B, Lu M, Pickhardt PJ, Menias CO, Abbas MA, Katz DS. Complications of Optical Colonoscopy: CT Findings. Radiol Clin North Am. 2014 Sep;52(5):1087-1099. doi: 10.1016/j.rcl.2014.05.012. Epub 2014 Jul 5. Review.

Daly BJ, Rosko A, Zhang S, Lazarus HM. The Devil is in the Details: Confidentiality Challenges in the Age of Genetics. HEC Forum. 2014 Aug 2. [Epub ahead of print]

Das M, Subbayya Ithychanda S, Qin J, Plow EF. Mechanisms of talin-dependent integrin signaling and crosstalk. Biochim Biophys Acta. 2014 Feb;1838(2):579-88.

Date D, Das R, Narla G, Simon DI, Jain MK, Mahabeleshwar GH. Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization. J Biol Chem. 2014 Jan 2. In press

Date DA, Burrows AC, Summers MK. Phosphorylation regulates the p31Comet-mitotic arrest-deficient 2 (Mad2) interaction to promote spindle assembly checkpoint (SAC) activity. J Biol Chem. 2014 Apr 18;289(16):11367-73. doi: 10.1074/jbc.M113.520841. Epub 2014 Mar 4.

Davare MA, Lal S, Peckham JL, Prajapati SI, Gultekin SH, Rubin BP, Keller C. Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):476-80. doi: 10.1016/j.ijrobp.2013.12.022.

Davuluri G, Augoff K, Schiemann WP, Plow EF, Sossey-Alaoui K. WAVE3-NFë¼B Interplay Is Essential for the Survival and Invasion of Cancer Cells. PLoS One. 2014. 9:e110627

de Lima M, Porter DL, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Schmid C. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and treatment of relapse after hematopoietic stem cell transplantation: Part III. Prevention and treatment of relapse after allogeneic transplantati Biol Blood Marrow Transplant. 2014 Jan;20(1):4-13.

de Melo Campos P, Machado-Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte AS, Barra FF, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leuk Res. 2014. 38:1245-51.

De S, Dermawan JK, Stark GR. EGF receptor uses SOS1 to drive constitutive activation of NF‘_B in cancer cells. Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11721-6. doi: 10.1073/pnas.1412390111. Epub 2014 Jul 28.

Deb G, Singh AK, Gupta S. EZH2: not EZHY (easy) to deal. Mol Cancer Res. 2014 May;12(5):639-53. doi: 10.1158/1541-7786.MCR-13-0546. Epub 2014 Feb 13.

Deb G, Thakur VS, Limaye AM, Gupta S. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol Carcinog. 2014 Jan 31. In press

Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ. A Phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers. Clin Colorectal Cancer. 2014 Jan 4 In press

Dermawan JK, Gurova K, Pink J, Dowlati A, De S, Narla G, Sharma N, Stark GR. Quinacrine Overcomes Resistance to Erlotinib by Inhibiting FACT, NF-‘_B, and Cell-Cycle Progression in Non-Small Cell Lung Cancer. Mol Cancer Ther. 2014 Sep;13(9):2203-14. doi: 10.1158/1535-7163.MCT-14-0013. Epub 2014 Jul 15.

Desai A, Qing Y, Gerson SL. Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells. Stem Cells. 2014 Feb;32(2):582-93.

Desai A, Webb B, Gerson SL. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells. Radiother Oncol. 2014 Mar;110(3):538-45. doi: 10.1016/j.radonc.2013.10.040. Epub 2014 Jan 16.

DeZern AE, Sekeres MA. The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure. J Natl Cancer Inst. 2014 Jun 4;106(6). doi:pii: dju130.  10.1093/jnci/dju130. Print 2014 Jun. No abstract available.

Di Stasi A, Milton DR, Poon LM, Hamdi A, Rondon G, Chen J, Pingali SR, Konopleva M, Kongtim P, Alousi A, Qazilbash MH, Ahmed S, Bashir Q, Al-Atrash G, Oran B, Hosing CM, Kebriaei P, Popat U, Shpall EJ, Lee DA, de Lima M, Rezvani K, et al. Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unrelated and Related Donors. Biol Blood Marrow Transplant. 2014. S1083-8791(14)00529-1.

Diaz-Montero CM, Finke J, Montero AJ. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol. 2014 Apr;41(2):174-84. doi: 10.1053/j.seminoncol.2014.02.003. Epub 2014 Feb 14. Review.

Diíeras V, Harbeck N, Budd GT, Greenson JK, Guardino AE, Samant M, Chernyukhin N, Smitt MC, Krop IE. Trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer: an integrated safety analysis. J Clin Oncol. 2014 Sep 1;32(25):2750-7. doi: 10.1200/JCO.2013.54.4999. Epub 2014 Jul 14.

Do JS, Visperas A, Freeman ML, Iwakura Y, Oukka M, Min B. Colitogenic effector T cells: roles of gut-homing integrin, gut antigen specificity and γδ T cells. Immunol Cell Biol. 2014 Jan;92(1):90-8.

Dotan E, Li T, Hall MJ, Meropol NJ, Beck JR, Wong YN. Oncologists' Response to New Data Regarding the Use of Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer. J Oncol Pract. 2014 Jul 22. doi:pii: JOP.2014.001439. [Epub ahead of print]

Dowlati A, Wildey G. Defining subgroups of small-cell lung cancer. J Thorac Oncol. 2014 Jun;9(6):750-1. doi: 10.1097/JTO.0000000000000176. No abstract available.

Dreicer R, MacLean D, Suri A, Stadler WM, Shevrin D, Hart L, MacVicar GR, Hamid O, Hainsworth J, Gross ME, Shi Y, Webb IJ, Agus DB. Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 2014 Mar 1;20(5):1335-44. doi: 10.1158/1078-0432.CCR-13-2436. Epub 2014 Jan 13.

Dreicer R, Maclean D, Suri A, Stadler WM, Shevrin D, Hart L, Macvicar GR, Hamid O, Hainsworth J, Gross ME, Shi Y, Webb IJ, Agus DB. Phase 1/2 trial of orteronel (TAK-700) - an investigational 17,20-lyase inhibitor - in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 2014 Jan 13. In press

Dreicer R. How to approach sequencing therapy in patients with metastatic castration resistant prostate cancer. Can J Urol. 2014 Apr;21(2 Supp 1):93-7.

Droz JP, Aapro M, Balducci L, Boyle H, Van den Broeck T, Cathcart P, Dickinson L, Efstathiou E, Emberton M, Fitzpatrick JM, Heidenreich A, Hughes S, Joniau S, Kattan M, Mottet N, Oudard S, Payne H, Saad F, Sugihara T. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. Lancet Oncol. 2014 Aug;15(9):e404-e414. doi: 10.1016/S1470-2045(14)70018-X. Review.

Du J, Li Q, Tang F, Puchowicz MA, Fujioka H, Dunwoodie SL, Danielpour D, Yang YC. Cited2 is required for the maintenance of glycolytic metabolism in adult hematopoietic stem cells. Stem Cells Dev. 2014 Jan 15;23(2):83-94.

Duska LR, Blessing JA, Rotmensch J, Mannel RS, Hanjani P, Rose PG, Dizon DS. A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2014. 135:44-8.

Egusa S, Ebrahem Q, Mahfouz RZ, Saunthararajah Y. Ligand exchange on gold nanoparticles for drug delivery and enhanced therapeutic index evaluated in acute myeloid leukemia models. Exp Biol Med (Maywood). 2014 May 30. doi:pii: 1535370214536648. [Epub ahead of print]

El-Serag HB, Xu F, Biyani P, Cooper GS. Bundling in Medicare patients undergoing bidirectional endoscopy. How often does it happen? Clin Gastroenterol Hepatol. 2014 Jan;12(1):58-63.

Elliott RM, Shenk RR, Thompson CL, Gilmore HL. Touch preparations for the intraoperative evaluation of sentinel lymph nodes after neoadjuvant therapy have high false-negative rates in patients with breast cancer. Arch Pathol Lab Med. 2014 Jun;138(6):814-8. doi: 10.5858/arpa.2013-0281-OA.

Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol. 2014 Apr 20;32(12):1277-80. doi: 10.1200/JCO.2013.53.8009. Epub 2014 Mar 17. No abstract available.

Escudier B, Michaelson MD, Motzer RJ, Hutson TE, Clark JI, Lim HY, Porfiri E, Zalewski P, Kannourakis G, Staehler M, Tarazi J, Rosbrook B, Cisar L, Hariharan S, Kim S, Rini BI. Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial. Br J Cancer. 2014 Jun 10;110(12):2821-8. doi: 10.1038/bjc.2014.244. Epub 2014 May 13.

Eswarappa SM, Potdar AA, Koch WJ, Fan Y, Vasu K, Lindner D, Willard B, Graham LM, DiCorleto PE, Fox PL. Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax. Cell. 2014 Jun 19;157(7):1605-18. doi: 10.1016/j.cell.2014.04.033.

Factor DC, Corradin O, Zentner GE, Saiakhova A, Song L, Chenoweth JG, McKay RD, Crawford GE, Scacheri PC, Tesar PJ. Epigenomic Comparison Reveals Activation of Seed" Enhancers during Transition from Naive to Primed Pluripotency." J Interferon Cytokine Res. 2014 Jun;34(6):455-63. doi: 10.1089/jir.2014.0007.

Fan Y, Potdar AA, Gong Y, Eswarappa SM, Donnola S, Lathia JD, Hambardzumyan D, Rich JN, Fox PL. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression throughÊHIF-1? accumulation. Nat Cell Biol. 2014. 16:445-56

Fang J, Barker B, Bolanos L, Liu X, Jerez A, Makishima H, Christie S, Chen X, Rao DS, Grimes HL, Komurov K, Weirauch MT, Cancelas JA, Maciejewski JP, Starczynowski DT. Myeloid Malignancies with Chromosome 5q Deletions Acquire a Dependency on an Intrachromosomal NF-‘_B Gene Network. Cell Rep. 2014 Sep 3. doi:pii: S2211-1247(14)00665-2.  10.1016/j.celrep.2014.07.062. [Epub ahead of print]

Fang X, Huang Z, Zhou W, Wu Q, Sloan AE, Ouyang G, McLendon RE, Yu JS, Rich JN, Bao S. The zinc finger transcription factor ZFX Is required for maintaining the tumorigenic potential of glioblastoma stem cells. Stem Cells. 2014 May 16. doi: 10.1002/stem.1730. [Epub ahead of print]

Fecteau RE, Lutterbaugh J, Markowitz SD, Willis J, Guda K. GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers. PLoS One. 2014 Jan 30;9(1):e87966.

Feng X, Scott A, Wang Y, Wang L, Zhao Y, Doerner S, Satake M, Croniger CM, Wang Z. PTPRT Regulates High-Fat Diet-Induced Obesity and Insulin Resistance. PLoS One. 2014;9(6):e100783. doi: 10.1371/journal.pone.0100783.

Feng Y, Minca EC, Lanigan C, Liu A, Zhang W, Yin L, Pennell NA, Farver C, Tubbs R, Ma PC. High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer. J Thorac Oncol. 2014 May;9(5):646-53. doi: 10.1097/JTO.0000000000000145.

Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, Perales MA, Rizzieri DA, Schouten HC, Smith SM, Waller EK, Wirk BM, Laport GG, Maloney DG, Montoto S, Hari PN. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: Analysis of transplantation timing and modality. J Clin Oncol. 2014 Feb 1;32(4):273-81. PMCID: PMC3897255

Fielding AK, Rowe JM, Buck G, Foroni L, Gerrard G, Litzow MR, Lazarus H, Luger SM, Marks DI, McMillan AK, Moorman AV, Patel B, Paietta E, Tallman MS, Goldstone AH. UKALLXII/ ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood. 2014 Feb 6;123(6):843-50.

Fink SP, Dawson DM, Zhang Y, Kresak A, Lawrence EG, Yang P, Chen Y, Barnholtz-Sloan JS, Willis JE, Kopelovich L, Markowitz SD. Sulindac Reversal of 15-PGDH Mediated Resistance to Colon Tumor Chemoprevention with NSAIDs. Carcinogenesis. 2014. In Press

Fink SP, Yamauchi M, Nishihara R, Jung S, Kuchiba A, Wu K, Cho E, Giovannucci E, Fuchs CS, Ogino S, Markowitz SD, Chan AT. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med. 2014 Apr 23;6(233):233re2. doi: 10.1126/scitranslmed.3008481.

Flocke SA, Clark E, Antognoli E, Mason MJ, Lawson PJ, Smith S, Cohen DJ. Teachable moments for health behavior change and intermediate patient outcomes. Patient Educ Couns. 2014 Jul;96(1):43-9. doi: 10.1016/j.pec.2014.03.014. Epub 2014 May 1.

Foulcer SJ, Day AJ, Apte SS. Isolation and purification of versican and analysis of versican proteolysis. Methods Mol Biol. 2015. 1229:587-604.

Franchi L, Eigenbrod T, Muñoz-Planillo R, Ozkurede U, Kim YG, Chakrabarti A, Gale M Jr, Silverman RH, Colonna M, Akira S, Núñez G. Cytosolic Double-Stranded RNA Activates the NLRP3 Inflammasome via MAVS-Induced Membrane Permeabilization and K+ Efflux. J Immunol. 2014. 193:4214-22.

Frazier TW, Embacher R, Tilot AK, Koenig K, Mester J, Eng C. Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry. 2014. in press

Freedman DA, Pe-Purcell N, Friedman DB, Ory M, Flocke S, Barni MT, Hobert JR. Extending cancer prevention to improve fruit and vegetable consumption. J Cancer Educ. 2014. 29:790-5.

French CA, Rahman S, Walsh EM, Kuhnle S, Grayson AR, Lemieux ME, Grunfeld N, Rubin BP, Antonescu CR, Zhang S, Venkatramani R, Dal Cin P, Howley PM. NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism. Cancer Discov. 2014 May 29. doi:pii: CD-14-0014. [Epub ahead of print]

Freyvogel M, Padia S, Larson K, Dietz J, Grobmyer S, O'Rourke C, Valente S. Screening Mammography Following Autologous Breast Reconstruction: An Unnecessary Effort. Ann Surg Oncol. 2014 Jul 25. [Epub ahead of print]

Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, Hayes MK, Copit DS, Carlson KL, Cink TM, Barke LD, Greer LN, Miller DP, Conant EF. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507. doi: 10.1001/jama.2014.6095.

Gale RP, Hlatky L, Sachs RK, Radivoyevitch T. Why is there so much therapy-related AML and MDS and so little therapy-related CML? Leuk Res. 2014. 38:1162-4.

Gale RP, Lazarus HM. Correcting 2 more myths regarding transplants for AML in second remission. Blood. 2014 Jan 30;123(5):794.

Gale RP, Wiernik PH, Lazarus HM. Should persons with acute myeloid leukemia have a transplant in first remission? Leukemia. 2014. 28:1949-52.

Gantt GA, Chen Y, Dejulius K, Mace AG, Barnholtz-Sloan J, Kalady MF. Gene expression profile is associated with chemoradiation resistance in rectal cancer. Colorectal Dis. 2014 Jan;16(1):57-66.

Gao Y, Goodnough CL, Erokwu BO, Farr GW, Darrah R, Lu L, Dell KM, Yu X, Flask CA. Arterial spin labeling-fast imaging with steady-state free precession (ASL-FISP): a rapid and quantitative perfusion technique for high-field MRI. NMR Biomed. 2014. 27:996-1004

Garcia JA, Elson P, Tyler A, Triozzi P, Dreicer R. Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): results from a phase I-II clinical trial. Urol Oncol. 2014 Jan;32(1):33.e11-7.

Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu Y, Schwartz JD, Thompson JA. A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Cancer. 2014 Jun 1;120(11):1647-55. doi: 10.1002/cncr.28634. Epub 2014 Feb 27.

Gerds AT, Sekeres MA. Initial transfusion frequency and survival in myelodysplastic syndromes: hopping onto a fast train to nowhere. Leuk Lymphoma. 2014. 55:2221-2.

Gerds AT. I walk the other line: myelodysplastic/myeloproliferative neoplasm overlap syndromes. Curr Hematol Malig Rep. 2014. 9:400-6.

Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. Satisfaction with information used to choose prostate cancer treatment. J Urol. 2014 May;191(5):1265-71. doi: 10.1016/j.juro.2013.12.008. Epub 2013 Dec 12.

Ginsburg SB, Viswanath SE, Bloch BN, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A. Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors. J Magn Reson Imaging. 2014 Jun 18. doi: 10.1002/jmri.24676. [Epub ahead of print]

Gittleman HR, Ostrom QT, Rouse CD, Dowling JA, de Blank PM, Kruchko CA, Elder JB, Rosenfeld SS, Selman WR, Sloan AE, Barnholtz-Sloan JS. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer. 2014 Aug 25. doi: 10.1002/cncr.29015. [Epub ahead of print]

Goodnough CL, Gao Y, Li X, Qutaish MQ, Goodnough LH, Molter J, Wilson D, Flask CA, Yu X. Lack of dystrophin results in abnormal cerebral diffusion and perfusion in vivo. Neuroimage. 2014 Nov 15;102 Pt 2:809-16.

Gotto GT, Yu C, Bernstein M, Eastham JA, Kattan MW. Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer. Front Oncol. 2014. 4:296.

Grady WM, Markowitz SD. The Molecular Pathogenesis of Colorectal Cancer and Its Potential Application to Colorectal Cancer Screening. Dig Dis Sci. 2014. In Press

Gragert L, Fingerson S, Albrecht M, Maiers M, Kalaycio M, Hill BT. Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations. Blood. 2014. 124:2657-65.

Guan D, Lim JH, Peng L, Liu Y, Lam M, Seto E, Kao HY. Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death. Cell Death Dis. 2014 Jul 17;5:e1340. doi: 10.1038/cddis.2014.185.

Guan X, Vengoechea J, Zheng S, Sloan AE, Chen Y, Brat DJ, O'Neill BP, de Groot J, Yust-Katz S, Yung WK, Cohen ML, Aldape KD, Rosenfeld S, Verhaak RG, Barnholtz-Sloan JS. Molecular subtypes of glioblastoma are relevant to lower grade glioma. PLoS One. 2014 Mar 10;9(3):e91216.

Guda K, Fink SP, Milne GL, Molyneaux N, Ravi L, Lewis SM, Dannenberg AJ, Montgomery CG, Zhang S, Willis J, Wiesner GL, Markowitz SD. Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance. Cancer Prev Res (Phila). 2014. 7:805-12.

Gujrati M, Malamas A, Shin T, Jin E, Sun Y, Lu ZR. Multifunctional Cationic Lipid-Based Nanoparticles Facilitate Endosomal Escape and Reduction-Triggered Cytosolic siRNA Release. Mol Pharm. 2014 Aug 4;11(8):2734-44. doi: 10.1021/mp400787s. Epub 2014 Jul 14.

Guo S, Cheng X, Lim JH, Liu Y, Kao HY. Control of antioxidative response by the tumor suppressor protein PML through regulating Nrf2 activity. Mol Biol Cell. 2014 Jun 18. doi:pii: mbc.E13-11-0692. [Epub ahead of print]

Gupta S, Sun H, Yi S, Storm J, Xiao G, Balasubramanian BA, Zhang S, Ashfaq R, Rockey DC. Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study. Cancer Prev Res (Phila). 2014. ;7:1023-34.

Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W. Reduced intensity hematopoietic cell transplantation for patients with primary myelofibrosis: A cohort analysis from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2014 Jan;20(1):89-97.

Halabi S, Rini B, Escudier B, Stadler WM, Small EJ. Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma. Cancer. 2014 Jan 1;120(1):52-60.  PMCID: PMC3869105

Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, Schmitt D, Neltner JM, Huang P, Ren B, Sloan AESilverstein RLGladson CL, DiDonato JABrown JM, McIntyre T, Hazen SL, Horbinski C, Rich JNLathia JD.  Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression. Stem Cells. 2014 Jul;32(7):1746-58. doi: 10.1002/stem.1716.

Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, et al. Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014. 20:1729-36.

Hamilton BK, Kalaycio M. Maximizing the Benefits of Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis. Biol Blood Marrow Transplant. 2014. 11:1869-70.

Hamilton BK, Rybicki L, Dabney J, McLellan L, Haddad H, Foster L, Abounader D, Kalaycio M, Sobecks R, Dean R, Duong H, Hill BT, Bolwell BJ, Copelan EA. Quality of life and outcomes in patients 60 years of age after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014. 49:1426-31.

Han X,  Zhang L,  Chung J,  Mayca Pozo F, Tran A,  Seachrist D,  Jacobberger JW Keri RA, Gilmore HZhang Y. UbcH7 regulates 53BP1 stability and DSB repair PNAS 2014. In Press

Han X, Aslanian A, Fu K, Tsuji T, Zhang Y. The Interaction between Checkpoint Kinase 1 (Chk1) and the Minichromosome Maintenance (MCM) Complex Is Required for DNA Damage-induced Chk1 Phosphorylation. J Biol Chem. 2014 Aug 29;289(35):24716-23. doi: 10.1074/jbc.M114.575035. Epub 2014 Jul 21.

Hao Y, Zhao S, Wang Z. Targeting the protein-protein interaction between IRS1 and mutant p110α for cancer therapy. Toxicol Pathol. 2014;42(1):140-7.

Harshman LC, Kroeger N, Rha SY, Donskov F, Wood L, Tantravahi SK, Vaishampayan U, Rini BI, Knox J, North S, Ernst S, Yuasa T, Srinivas S, Pal S, Heng DY, Choueiri TK. First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium. Clin Genitourin Cancer. 2014. 12:335-40.

He H, Magi-Galluzzi C. Epithelial-to-mesenchymal transition in renal neoplasms. Adv Anat Pathol. 2014 May;21(3):174-80. doi: 10.1097/PAP.0000000000000018.

Heald B, Eng C. Time studies of the tasks associated with comprehensive cancer genetics counseling. J Natl Compr Canc Netw. 2014 Mar 1;12(3):303. No abstract available.

Henderson CJ, Ngeow J, Collins MH, Martin LJ, Putnam PE, Abonia JP, Marsolo K, Eng C, Rothenberg ME. Increased prevalence of eosinophilic gastrointestinal disorders (EGID) in pediatric PTEN hamartoma tumor syndromes (PHTS). J Pediatr Gastroenterol Nutr. 2014 In press

Heng DY, Choueiri TK, Rini BI, Lee J, Yuasa T, Pal SK, Srinivas S, Bjarnason GA, Knox JJ, Mackenzie M, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Wood LA. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. Ann Oncol. 2014 Jan;25(1):149-54.

Heng DY, Wells JC, Rini BI, Beuselinck B, Lee JL, Knox JJ, Bjarnason GA, Pal SK, Kollmannsberger CK, Yuasa T, Srinivas S, Donskov F, Bamias A, Wood LA, Ernst DS, Agarwal N, Vaishampayan UN, Rha SY, Kim JJ, Choueiri TK. Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. 2014 Jun 12. doi:pii: S0302-2838(14)00494-1.  10.1016/j.eururo.2014.05.034. [Epub ahead of print]

Heylman CM, Santoso S, Krebs MD, Saidel GM, Alsberg E, Muschler GF. Modeling and experimental methods to predict oxygen distribution in bone defects following cell transplantation. Med Biol Eng Comput. 2014 In press

Hill BT, Caimi P, Kindwall-Keller T, Habecker B, Kalaycio M. Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL). Br J Haematol. 2014 Jan;164(2):297-9.

Hinman MN, Sharma A, Luo G, Lou H. Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons. Mol Cell Biol. 2014 Jun 15;34(12):2188-2197. Epub 2014 Apr 7.

Holtzhausen A, Golzio C, How T, Lee YH, Schiemann WP, Katsanis N, Blobe GC. Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development. FASEB J. 2014 Mar;28(3):1248-67. doi: 10.1096/fj.13-239178. Epub 2013 Dec 5.

Hong B, Li H, Lu Y, Zhang M, Zheng Y, Qian J, Yi Q. USP18 is crucial for IFN-ë_-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity. BMC Med Ethics. 2014 May 13;15(1):38. doi: 10.1186/1472-6939-15-38.

Hong B, Li H, Zhang M, Xu J, Lu Y, Zheng Y, Qian J, Chang JT, Yang J, Yi Q. p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion. Int J Cancer. 2015. 136:34-43.

Hourigan CS, McCarthy P, de Lima M. Reprint of: Back to the Future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Feb;20(2S):S8-S17.

Hsi ED, Said J, Macon WR, Rodig SJ, Ondrejka SL, Gascoyne RD, Morgan EA, Dorfman DM, Maurer MJ, Dogan A. Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol. 2014 Jun;38(6):768-75. doi: 10.1097/PAS.0000000000000188.

Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani B, Schears RM, Shaw BE, Confer DL. Race and ethnicity influences collection of G-CSF mobilized peripheral blood progenitor cells from unrelated donors, a CIBMTR analysis. Biol Blood Marrow Transplant. 2014. in press

Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, Luo B, Alvarez-Carbonell D, Garcia-Mesa Y, Karn J, Mo X, Khalili K. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11461-6. doi: 10.1073/pnas.1405186111. Epub 2014 Jul 21.

Huang Y, Didonato JA, Levison BS, Schmitt D, Li L, Wu Y, Buffa J, Kim T, Gerstenecker GS, Gu X, Kadiyala CS, Wang Z, Culley MK, Hazen JE, Didonato AJ, Fu X, Berisha SZ, Peng D, Nguyen TT, Liang S, Chuang CC, Cho L, Plow EF, Fox PL, Gogonea V, Tang WH, Parks JS, Fisher EA, Smith JD, Hazen SL An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med. 2014 Jan 26 In press

Hudson CD, Hagemann T, Mather SJ, Avril N. Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma. Cell Death Dis. 2014 Apr 10;5:e1160. doi: 10.1038/cddis.2014.125.

Hughes TP, Saglio G, Kantarjian HM, Guilhot F, Niederwieser D, Rosti G, Nakaseko C, De Souza CA, Kalaycio ME, Meier S, Fan X, Menssen HD, Larson RA, Hochhaus A. Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib. Blood. 2014. In press

Hutson TE, Bukowski RM, Rini BI, Gore ME, Larkin JM, Figlin RA, Barrios CH, Escudier B, Lin X, Fly K, Martell B, Matczak E, Motzer RJ. Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma. Br J Cancer. 2014 Mar 4;110(5):1125-32. doi: 10.1038/bjc.2013.832. Epub 2014 Jan 16.

Ibrahim O, Gastman B, Zhang A. Advances in diagnosis and treatment of nonmelanoma skin cancer. Ann Plast Surg. 2014. 73:615-9.

Ignatz-Hoover JJ, Wang H, Moreton SA, Chakrabarti A, Agarwal MK, Sun K, Gupta K, Wald DN. The role of TLR8 signaling in acute myeloid leukemia differentiation. Leukemia. 2014. in press

Jabbour E, Daver N, Champlin R, Mathisen M, Oran B, Ciurea S, Khouri I, Cornelison AM, Ghanem H, Cardenas-Turanzas M, Popat U, Ravandi F, Giralt S, Garcia-Manero G, Kantarjian H, de Lima M. Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy. Am J Hematol. 2014 In press

Jabbour MN, Seoud M, Al-Ahmadie H, Abdul-Karim FW, Zaatari GS. ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma. Int J Gynecol Pathol. 2014 May;33(3):263-7. doi: 10.1097/PGP.0b013e318290407c.

Jaber JJ, Zender CA, Mehta V, Davis K, Ferris RL, Lavertu P, Rezaee R, Feustel PJ, Johnson JT. A multi-institutional investigation of the prognostic value of lymph nodal yield in advanced stage oral cavity squamous cell carcinoma (OCSCC). Head Neck. 2014 In press

Jaini R, Rayman P, Cohen PA, Finke JH, Tuohy VK. Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy. Int J Cancer. 2014 Apr 1;134(7):1695-705. doi: 10.1002/ijc.28488. Epub 2013 Oct 8.

Jeon O, Samorezov JE, Alsberg E. Single and dual-crosslinked oxidized, methacrylated alginate/PEG hydrogels for bioadhesive applications. Acta Biomater. 2014 Jan;10(1):47-55.  PMCID: PMC3840035

Jia J, Arif A, Terenzi F, Willard B, Plow EF, Hazen SL, Fox PL. Target-selective protein s-nitrosylation by sequence motif recognition. Cell. 2014. 159:623-34.

Joshi P, Jacobs B, Derakhshan A, Moore LR, Elson P, Triozzi PL, Borden E, Zborowski M. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma. Oncotarget. 2014. 5:2450-61.

Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn JY, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014 Apr;49(4):477-84. doi: 10.1038/bmt.2013.211. Epub 2014 Jan 13.

Junk DJ, Bryson BL, Jackson MW. HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression. Cancers (Basel). 2014 Mar 26;6(2):741-55. doi: 10.3390/cancers6020741.

Kaiboriboon K, Schiltz NK, Bakaki PM, Lhatoo SD, Koroukian SM. Premature mortality in poor health and low income adults with epilepsy. Epilepsia. 2014. 55:1781-8.

Kalakonda S, Nallar SC, Lindner DJ, Sun P, Lorenz RR, Lamarre E, Reddy SP, Kalvakolanu DV. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis. Oncogene. 2014 Jun 12;33(24):3195-204. doi: 10.1038/onc.2013.271. Epub 2013 Jul 15.

Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D, Wen P. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol. 2014 Jun;16(6):829-40. doi: 10.1093/neuonc/not330. Epub 2014 Feb 4.

Kandanapitiye MS, Gao M, Molter J, Flask CA, Huang SD. Synthesis, characterization, and X-ray attenuation properties of ultrasmall BiOI nanoparticles: toward renal clearable particulate CT contrast agents. Inorg Chem. 2014. 53:10189-94.

Kanwal R, Pandey M, Bhaskaran N, Maclennan GT, Fu P, Ponsky LE, Gupta S. Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog. 2014 Jan;53(1):8-18.

Karunamuni GH, Gu S, Ford MR, Peterson LM, Ma P, Wang YT, Rollins AM, Jenkins MW, Watanabe M. Capturing structure and function in an embryonic heart with biophotonic tools. Front Physiol. 2014. In Press

Keire PA, Bressler SL, Lemire JM, Edris B, Rubin BP, Rahmani M, McManus BM, van de Rijn M, Wight TN. A role for versican in the development of leiomyosarcoma. J Biol Chem. 2014. in press

Kelly ML, Kshettry VR, Rosenbaum BP, Seicean A, Weil RJ. Effect of a randomized controlled trial on the surgical treatment of spinal metastasis, 2000 through 2010: a population-based cohort study. Cancer. 2014 Mar 15;120(6):901-8. doi: 10.1002/cncr.28497. Epub 2013 Dec 10.

Kenison TC, Silverman P, Sustin M, Thompson CL. Differences between nurse practitioner and physician care providers on rates of secondary cancer screening and discussion of lifestyle changes among breast cancer survivors. J Cancer Surviv. 2014.in press

Khambati HK, Choueiri TK, Kollmannsberger CK, North S, Bjarnason GA, Vaishampayan UN, Wood L, Knox JJ, Tan MH, MacKenzie MJ, Donskov F, Rini BI, Heng DY; International mRCC Database Consortium. Efficacy of targeted therapy for metastatic renal cell carcinoma in the elderly patient population. Clin Genitourin Cancer. 2014. 12:354-8.

Khor LY, Abdul-Karim FW, Bruening AE, Weber Noffsinger DK, Booth CN. Papanicolaou tests with coexisting squamous and glandular abnormalities. Cancer Cytopathol. 2014 Jun 17. doi: 10.1002/cncy.21448. [Epub ahead of print]

Khorana AA, McCrae KR. Risk stratification strategies for cancer-associated thrombosis: an update. Thromb Res. 2014 May;133 Suppl 2:S35-8. doi: 10.1016/S0049-3848(14)50006-0.

Khorana AA, Otten HM, Zwicker JI, Connolly GC, Bancel DF, Pabinger I; Subcommittee on Haemostasis and Malignancy. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH. J Thromb Haemost. 2014. 12:1928-31.

Khorana AA, Rubens D, Francis CW. Screening high-risk cancer patients for VTE: A prospective observational study. Thromb Res. 2014. in press

Kim H, Fabien J, Zheng Y, Yuan J, Brindle J, Sloan A, Yao M, Lo S, Wessels B, Machtay M, Welford S, Sohn JW. Establishing a process of irradiating small animal brain using a CyberKnife and a microCT scanner. Med Phys. 2014 Feb;41(2):021715.

Kim H, Park SB, Monroe JI, Traughber BJ, Zheng Y, Lo SS, Yao M, Mansur D, Ellis R, Machtay M, Sohn JW. Quantitative Analysis Tools and Digital Phantoms for Deformable Image Registration Quality Assurance. Technol Cancer Res Treat. 2014. in press

Kim JG, Kim TO, Bae JH, Shim JW, Kang MJ, Yang K, Ting AH, Yi JM. Epigenetically regulated MIR941 and MIR1247 target gastric cancer cell growth and migration. Epigenetics. 2014 May 28;9(7). [Epub ahead of print]

Klein EA, Cooperberg MR, Carroll PR. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's Letter to the Editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, T Eur Urol. 2014 Aug 19. doi:pii: S0302-2838(14)00743-X.  10.1016/j.eururo.2014.08.001. [Epub ahead of print] No abstract available.

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. Eur Urol. 2014 May 16. doi:pii: S0302-2838(14)00414-X.  10.1016/j.eururo.2014.05.004. [Epub ahead of print]

Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E. A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy. Eur Urol. 2014.  pii: S0302-2838:01125-7.

Klein EA. Seeing and Not Believing: Oligometastases and the Future of Metastatic Prostate Cancer. Eur Urol. 2014.  in press

Ko JJ, Choueiri TK, Rini BI, Lee JL, Kroeger N, Srinivas S, Harshman LC, Knox JJ, Bjarnason GA, MacKenzie MJ, Wood L, Vaishampayan UN, Agarwal N, Pal SK, Tan MH, Rha SY, Yuasa T, Donskov F, Bamias A, Heng DY. First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. Br J Cancer. 2014 Apr 15;110(8):1917-22. doi: 10.1038/bjc.2014.25. Epub 2014 Apr 1.

Ko JS, Billings SD, Lanigan CP, Buehler D, Fernandez AP, Tubbs RR. Fully automated dual-color dual-hapten silver in-situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma. J Cutan Pathol. 2014 In press

Kohan A, Avril NE. Pelvis: normal variants and benign findings in FDG-PET/CT imaging. PET Clin. 2014 Apr;9(2):185-93. doi: 10.1016/j.cpet.2013.10.002. Epub 2013 Dec 10.

Kohli N, Honda KS, Bordeaux JS. Pigment occurrence in skin graft donor sites. Dermatol Surg. 2014 Feb;40(2):221-4.

Kondziolka D, Kalkanis SN, Mehta MP, Ahluwalia M, Loeffler JS. It is time to reevaluate the management of patients with brain metastases. Neurosurgery. 2014 Jul;75(1):1-9. doi: 10.1227/NEU.0000000000000354.

Kondziolka D, Parry PV, Lunsford LD, Kano H, Flickinger JC, Rakfal S, Arai Y, Loeffler JS, Rush S, Knisely JP, Sheehan J, Friedman W, Tarhini AA, Francis L, Lieberman F, Ahluwalia MS, Linskey ME, McDermott M, Sperduto P, Stupp R. The accuracy of predicting survival in individual patients with cancer. J Neurosurg. 2014 Jan;120(1):24-30.

Koon HB, Krown SE, Lee JY, Honda K, Rapisuwon S, Wang Z, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II trial of Imatinib in AIDS-associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol. 2014. In press

Korn JM, Tellez-Diaz A, Bartz-Kurycki M, Gastman B. Indocyanine green SPY elite-assisted sentinel lymph node biopsy in cutaneous melanoma. Plast Reconstr Surg. 2014 Apr;133(4):914-22. doi: 10.1097/PRS.0000000000000006.

Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar;106(3):djt456. doi: 10.1093/jnci/djt456. Epub 2014 Feb 22.

Kroeger N, Choueiri TK, Lee JL, Bjarnason GA, Knox JJ, MacKenzie MJ, Wood L, Srinivas S, Vaishamayan UN, Rha SY, Pal SK, Yuasa T, Donskov F, Agarwal N, Tan MH, Bamias A, Kollmannsberger CK, North SA, Rini BI, Heng DY. Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. Eur Urol. 2014 Jun;65(6):1086-92. doi: 10.1016/j.eururo.2013.07.031. Epub 2013 Jul 30.

Kshettry VR, Rosenbaum BP, Seicean A, Kelly ML, Schiltz NK, Weil RJ. Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2014. 21:282-6.

Kuang Y, Wang F, Corn DJ, Tian H, Lee Z. Metabolism of radiolabeled methionine in hepatocellular carcinoma. Mol Imaging Biol. 2014 Feb;16(1):44-52.

Kunos CA, Sherertz TM. Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer. Front Oncol. 2014;4:184. doi: 10.3389/fonc.2014.00184.

Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, Nakashima M, Hsi ED, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Boultwood J, Makishima H, Maciejewski JP, Padgett RA. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia. 2014 Apr 30. doi: 10.1038/leu.2014.144. [Epub ahead of print]

Kypriotakis G, Francis LE, O'Toole E, Towe TP, Rose JH. Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation. Support Care Cancer. 2014 May;22(5):1251-9. doi: 10.1007/s00520-013-2079-x. Epub 2013 Dec 7.

Lafata JE, Cooper G, Divine G, Oja-Tebbe N, Flocke SA. Patient-physician colorectal cancer screening discussion content and patients' use of colorectal cancer screening. Patient Educ Couns. 2014 Jan;94(1):76-82. PMCID: PMC3865022

Lai RK, Chen Y, Guan X, Nousome D, Sharma C, Canoll P, Bruce J, Sloan AE, Cortes E, Vonsattel JP, Su T, Delgado-Cruzata L, Gurvich I, Santella RM, Ostrom Q, Lee A, Gregersen P, Barnholtz-Sloan J. Genome-wide methylation analyses in glioblastoma multiforme. PLoS One. 2014 Feb 21;9(2):e89376.

Lathia JD, Li M, Sinyuk M, Alvarado AG, Flavahan WA, Stoltz K, Rosager AM, Hale J, Hitomi M, Gallagher J, Wu Q, Martin J, Vidal JG, Nakano I, Dahlrot RH, Hansen S, McLendon RE, Sloan AE, Bao S, Hjelmeland AB, Carson CT, Naik UP, Kristensen B, Rich JN. High-throughput flow cytometry screening reveals a role for junctional adhesion molecule A as a cancer stem cell maintenance factor. Cell Rep. 2014 Jan 16;6(1):117-29. PMCID: PMC3899718

Lathia JD. Cancer stem cells: moving past the controversy. CNS Oncol. 2013 Nov;2(6):465-7. doi: 10.2217/cns.13.42. No abstract available.

Lathia JD. Modeling mayhem: predicting invasion and proliferation kinetics in IDH1 mutant glioblastoma with mathematical models. Neuro Oncol. 2014 Jun;16(6):763-4. doi: 10.1093/neuonc/nou062. Epub 2014 Apr 15. No abstract available.

Lazaryan A, Hussein MA, Reu FJ, Faiman B, Habecker B, Ann Karam M, Reed J, Hamilton K, Waksman J, Bruening K, Srkalovic G, Andresen S, Kalaycio M, Sweetenham JW, Sobecks R, Dean R, Knight R, Zeldis JB, Baz R. Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma. Am J Hematol. 2014 Apr;89(4):349-54. doi: 10.1002/ajh.23639. Epub 2014 Feb 24.

Le QT, Machtay M. Acceler-dated fractionation: the end of the era of the large, one size fits all" trial for locally advanced head and neck cancer." Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):7-9. doi: 10.1016/j.ijrobp.2014.01.045. No abstract available.

Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA, Freytes CO, Miller AM, Vose JM, Maziarz RT, Montoto S, Maloney DG, Hari PN. Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone Marrow Transplant. 2014. 49:1360-5.

Leder K, Pitter K, Laplant Q, Hambardzumyan D, Ross BD, Chan TA, Holland EC, Michor F. Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell. 2014 Jan 30;156(3):603-16.

Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ. Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer-Specific Mortality by Nomogram-predicted Risks of Biochemical Recurrence. Eur Urol. 2014. pii: S0302-2838(14)00912-9. doi:

Lee BS, Juthani RG, Healy AT, Peereboom DM, Recinos VM. Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma. Surg Neurol Int. 2014;5(Suppl 4):S175-80. doi: 10.4103/2152-7806.136741.

Lee G, Singanamalli A, Wang H, Feldman M, Master S, Shih N, Spangler E, Rebbeck T, Tomaszewski J, Madabhushi A. Supervised Multi-View Canonical Correlation Analysis (sMVCCA): Integrating histologic and proteomic features for predicting recurrent prostate cancer. IEEE Trans Med Imaging. 2014. In Press

Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. PLoS One. 2014;9(5):e97954. doi: 10.1371/journal.pone.0097954.

Lee KL, Uhde-Holzem K, Fischer R, Commandeur U, Steinmetz NF. Genetic engineering and chemical conjugation of potato virus x. Methods Mol Biol. 2014;1108:3-21.

Lemonovich TL, Watkins RR, Morrison CS, Kwok C, Chipato T, Musoke R, Arts EJ, Nankya I, Salata RA. Differences in clinical manifestations of acute and early HIV-1 infection between HIV-1 subtypes in African women. J Int Assoc Provid AIDS Care. 2014 In press

Lewis JS Jr, Ali S, Luo J, Thorstad WL, Madabhushi A. A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2014 Jan;38(1):128-37. PMCID: PMC3865861

Li L, Hu B, Kattan MW. Modeling potential time to event data with competing risks. Lifetime Data Anal. 2014 Apr;20(2):316-34. doi: 10.1007/s10985-013-9279-z. Epub 2013 Sep 24.

Li Q, Hakimi P, Liu X, Yu WM, Ye F, Fujioka H, Raza S, Shankar E, Tang F, Dunwoodie SL, Danielpour D, Hoppel CL, Ramírez-Bergeron DL, Qu CK, Hanson RW, Yang YC. Cited2, a transcriptional modulator protein, regulates metabolism in murine embryonic stem cells. J Biol Chem. 2014 Jan 3;289(1):251-63.  PMCID: PMC3879548

Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ, Shah N, Sorror ML, Wood WA, Majhail NS. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Biol Blood Marrow Transplant. 2014 Apr;20(4):587-92. doi: 10.1016/j.bbmt.2013.12.567. Epub 2014 Jan 2.

Li Y, Tu Z, Qian S, Fung JJ, Markowitz SD, Kusner LL, Kaminski HJ, Lu L, Lin F. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis. J Immunol. 2014. 193:2127-34.

Liang Y, Ketchum NS, Goodman PJ, Klein EA, Thompson IM Jr. Is there a role for body mass index in the assessment of prostate cancer risk on biopsy? J Urol. 2014. 192:1094-9.

Lim JW, Paek MS, Shon EJ. Gender and Role Differences in Couples' Communication During Cancer Survivorship. Cancer Nurs. 2014 Aug 13. [Epub ahead of print]

Lin L, Zhu J, Kottke-Marchant K, Marchant RE. Biomimetic engineered poly (ethylene glycol) hydrogel for smooth muscle cell migration. Tissue Eng Part A. 2014 Jan 9 In press

Lin P, Correa D, Kean TJ, Awadallah A, Dennis JE, Caplan AI. Serial transplantation and long-term engraftment of intraarterially delivered clonally-derived mesenchymal stem cells to injured bone marrow. Mol Ther. 2014 Jan;22(1):160-8.

Lindner D. Animal models and the tumor microenvironment: studies of tumor-host symbiosis. Semin Oncol. 2014 Apr;41(2):146-55. doi: 10.1053/j.seminoncol.2014.02.004. Epub 2014 Feb 14. Review.

List AF, Bennett JM, Sekeres MA, Skikne B, Fu T, Shammo JM, Nimer SD, Knight RD, Giagounidis A; MDS-003 Study Investigators. Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS. Leukemia. 2014 May;28(5):1033-40. doi: 10.1038/leu.2013.305. Epub 2013 Oct 22.

Litjens G, Toth R, van de Ven W, Hoeks C, Kerkstra S, van Ginneken B, Vincent G, Guillard G, Birbeck N, Zhang J, Strand R, Malmberg F, Ou Y, Davatzikos C, Kirschner M, Jung F, Yuan J, Qiu W, Gao Q, Edwards PE, Maan B, van der Heijden F, Ghose S, Mitra J, Dowling J, Barratt D, Huisman H, Madabhushi A. Evaluation of prostate segmentation algorithms for MRI: the PROMISE12 challenge. Med Image Anal. 2014. 18:359-73. PMCID: PMC4137968

Liu JK, Lubelski D, Schonberg DL, Wu Q, Hale JS, Flavahan WA, Mulkearns-Hubert EE, Man J, Hjelmeland AB, Yu J, Lathia JD, Rich JN. Phage display discovery of novel molecular targets in glioblastoma-initiating cells. 2014. 21:1325-39.

Liu Y, Tabarroki A, Billings S, Visconte V, Rogers HJ, Hasrouni E, Englehaupt R, Kalaycio M, Sekeres MA, Saunthararajah Y, Tiu RV. Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet's syndrome that was refractory to 5-azacitidine. Leuk Lymphoma. 2014 Feb;55(2):447-9.

Liu Z, Ciocea A, Devireddy L. Endogenous siderophore 2,5-dihydroxybenzoic Acid deficiency promotes anemia and splenic iron overload in mice. Mol Cell Biol. 2014 Jul 1;34(13):2533-46. doi: 10.1128/MCB.00231-14. Epub 2014 Apr 28.

Liu Z, Velpula KK, Devireddy L. 3-Hydroxybutyrate dehydrogenase-2 and ferritin-H synergistically regulate intracellular iron. FEBS J. 2014 May;281(10):2410-21. doi: 10.1111/febs.12794. Epub 2014 Apr 11.

Liu Z, Xu J, He J, Zheng Y, Li H, Lu Y, Qian J, Lin P, Weber DM, Yang J, Yi Q. A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood. 2014 Jul 21. doi:pii: blood-2014-03-557298. [Epub ahead of print]

Lo SS, Loblaw A, Chang EL, Mayr NA, Teh BS, Huang Z, Yao M, Ellis RJ, Biswas T, Sohn JW, Machtay M, Sahgal A. Emerging applications of stereotactic body radiotherapy. Future Oncol. 2014 May;10(7):1299-310. doi: 10.2217/fon.14.13.

Lo SS, Sahgal A, Slotman BJ, Mansur DB, Khouri A, Sloan AE, Machtay M, Chang EL. What is the most appropriate clinical target volume for glioblastoma? CNS Oncol. 2013 Sep;2(5):419-25. doi: 10.2217/cns.13.38.

Lo SS, Sloan AE, Machtay M. Stereotactic radiosurgery for more than four brain metastases. Lancet Oncol. 2014 Apr;15(4):362-3. doi: 10.1016/S1470-2045(14)70076-2. Epub 2014 Mar 10. No abstract available.

Lorusso PM, Krishnamurthi S, Youssoufian H, Hall N, Fox F, Dontabhaktuni A, Grebennik D, Remick S. Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. Invest New Drugs. 2014 In press.

Loughran TP Jr, Zickl L, Olson TL, Wang V, Zhang D, Rajala HL, Hasanali Z, Bennett JM, Lazarus HM, Litzow MR, Evens AM, Mustjoki S, Tallman MS. Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the eastern cooperative oncology group (E5998). Leukemia. 2014.in press

Lu F, Doane TL, Zhu JJ, Burda C. A method for separating PEGylated Au nanoparticle ensembles as a function of grafting density and core size. Chem Commun (Camb). 2014 Jan 21;50(6):642-4.

Lu L, Donnola SB, Koontz M, Griswold MA, Duerk JL, Flask CA . Lipid elimination with an echo-shifting N/2-ghost acquisition (LEENA) MRI Magn Reson Med. 2014. In Press

Lu Y, Wang Q, Yi Q. Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy. Oncoimmunology. 2014;3:e28542.

Lukenbill J, Hill B. Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients. Leuk Lymphoma. 2014 Jun 16:1-8. [Epub ahead of print]

Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM. Differences in DNA Methylation Signatures Reveal Multiple Pathways of Progression From Adenoma to Colorectal Cancer. Gastroenterology. 2014 Apr 30. doi:pii: S0016-5085(14)00595-2.  10.1053/j.gastro.2014.04.039. [Epub ahead of print]

Ly B, Modi A, Rogers HJ, Makishima H, Hanna R, Cook JR, Theil KS, Maciejewski JP. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS. Pediatr Blood Cancer. 2014 May;61(5):946-8. doi: 10.1002/pbc.24797. Epub 2013 Oct 8.

Lyons JA, Sherertz T Postmastectomy radiation therapy. Curr Oncol Rep. 2014 Jan;16(1):361.

Ma J, Tang X, Wong P, Jacobs B, Borden EC, Bedogni B. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation. J Biol Chem. 2014 Mar 21;289(12):8442-9. doi: 10.1074/jbc.M113.516039. Epub 2014 Feb 3.

Ma L, Kerr BA, Naga Prasad SV, Byzova TV, Somanath PR. Differential effects of Akt1 signaling on short- versus long-term consequences of myocardial infarction and reperfusion injury. Lab Invest. 2014 Jul 21. doi: 10.1038/labinvest.2014.95. [Epub ahead of print]

Ma S, Rubin BP. Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma. Lab Invest. 2014 Apr;94(4):430-8. doi: 10.1038/labinvest.2014.13. Epub 2014 Mar 3.

Machtay M, Bradley JD, Curran WJ. Clinical trials in thoracic radiation oncology: as easy as 1, 2, 3. Int J Radiat Oncol Biol Phys. 2014. 90:490-2.

Maciel J, Oliveira MI, Colton E, McNally AK, Oliveira C, Anderson JM, Barbosa M. Adsorbed fibrinogen enhances production of bone- and angiogenic-related factors by monocytes/macrophages. Tissue Eng Part A. 2014 Jan;20(1-2):250-63. PMCID: PMC3875152

Maggiore RJ, Dale W, Gross CP, Feng T, Tew WP, Mohile SG, Owusu C, Klepin HD, Lichtman SM, Gajra A, Ramani R, Katheria V, Zavala L, Hurria A Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc. 2014. 62:1505-12. PMCID: PMC4134360

Mah WC, Thurnherr T, Chow PK, Chung AY, Ooi LL, Toh HC, Teh BT, Saunthararajah Y, Lee CG. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis. PLoS One. 2014;9(8):e104158. doi: 10.1371/journal.pone.0104158.

Mahal BA, Chen MH, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV, Nguyen PL. The association between race and treatment regret among men with recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2014. in press

Mahdi H, Mester JL, Nizialek EA, Ngeow J, Michener C, Eng C. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with cowden and cowden-like syndromes: An international, multicenter, prospective study. Cancer. 2014. in press

Man J, Shoemake J, Zhou W, Fang X, Wu Q, Rizzo A, Prayson R, Bao S, Rich JN, Yu JS. Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation. Cell Rep. 2014. 9:1812-26

Manne S, Kashy D, Albrecht T, Wong YN, Flamm AL, Benson AB 3rd, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ. Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: A mediational model. Med Decis Making. 2014 In press.

Mansur DB. Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center. Expert Rev Anticancer Ther. 2014 Sep;14(9):1001-5. doi: 10.1586/14737140.2014.948857. Epub 2014 Aug 11.

Mansur DB. Multidisciplinary management of pediatric intracranial ependymoma. CNS Oncol. 2013 May;2(3):247-57. doi: 10.2217/cns.13.13.

Mao FJ, Rini BI. The ineligible patient: how to treat patients not included in clinical studies. World J Urol. 2014 Feb;32(1):9-18.

Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE. Extent of resection of glioblastoma revisited: Personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol. 2014 Feb 10. In press

Marks DI, Woo KA, Zhong X, Appelbaum FR, Bachanova V, Barker JN, Brunstein CG, Gibson J, Kebriaei P, Lazarus HM, Olsson R, Perales MA, Pidala J, Savani B, Rocha V, Eapen M. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Haematologica. 2014 Feb;99(2):322-8. PMCID: PMC3912963

Maroto P, Rini B. Molecular biomarkers in advanced renal cell carcinoma. Clin Cancer Res. 2014 Apr 15;20(8):2060-71. doi: 10.1158/1078-0432.CCR-13-1351. Epub 2014 Feb 13.

Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Strenski T, Zhou J, Rotimi CN. Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria. BMC Med Ethics. 2014 May 13;15:38. doi: 10.1186/1472-6939-15-38. PMCID: PMC4032563

Martin BN, Wang C, Willette-Brown J, Herjan T, Gulen MF, Zhou H, Bulek K, Franchi L, Sato T, Alnemri ES, Narla G, Zhong XP, Thomas J, Klinman D, Fitzgerald KA, Karin M, Nuñez G, Dubyak G, Hu Y, Li X. IKKα negatively regulates ASC-dependent inflammasome activation. Nat Commun. 2014. 5:4977

Martinez EE, Darke AK, Tangen CM, Goodman PJ, Fowke JH, Klein EA, Abdulkadir SA. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Blood. 2014 Jun 3. doi:pii: blood-2014-04-571091. [Epub ahead of print]

Martires KJ, Kurlander DE, Minwell GJ, Dahms EB, Bordeaux JS. Patterns of cancer screening in primary care from 2005 to 2010. Cancer. 2014 Jan 15;120(2):253-61.

Marwarha G, Berry DC, Croniger CM, Noy N. The retinol esterifying enzyme LRAT supports cell signaling by retinol-binding protein and its receptor STRA6. FASEB J. 2014 Jan;28(1):26-34. PMCID: PMC3868835

Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Minn AJ, Simon MC miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):291-6. PMCID: PMC3890843

Mayer EL, Gropper AB, Harris L, Gold JM, Parker L, Kuter I, Come S, Najita JS, Guo H, Winer EP, Burstein HJ. Long-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer. Clin Breast Cancer. 2014 Aug 15. doi:pii: S1526-8209(14)00165-7.  10.1016/j.clbc.2014.07.010. [Epub ahead of print]

McCarroll ML, Armbruster S, Frasure HE, Gothard MD, Gil KM, Kavanagh MB, Waggoner S, von Gruenigen VE. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): A randomized controlled trial. Gynecol Oncol. 2014 In press

McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, et a Allotransplantation for patients age 䊫40 years with non-hodgkin lymphoma: encouraging progression-free survival. Biol Blood Marrow Transplant. 2014 Jul;20(7):960-8. doi: 10.1016/j.bbmt.2014.03.013. Epub 2014 Mar 15.

McKay RR, Kroeger N, Xie W, Lee JL, Knox JJ, Bjarnason GA, Mackenzie MJ, Wood L, Srinivas S, Vaishampayan UN, Rha SY, Pal SK, Donskov F, Tantravahi SK, Rini BI, Heng DY, Choueiri TK. Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. Eur Urol. 2014 Mar;65(3):577-84.

McMahon S, Laframboise T. Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis. 2014 Jan 18. In press

McNamara MJ, Adelstein DJ, Bodmann JW, Greskovich JF Jr, Ives DI, Mason DP, Murthy SC, Rice TW, Saxton JP, Sohal D, Stephans K, Rodriguez CP, Videtic GM, Rybicki LA. A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesoph J Thorac Oncol. 2014 Aug 28. [Epub ahead of print]

McNeel DG, Gardner TA, Higano CS, Kantoff PW, Small EJ, Wener MH, Sims RB, DeVries T, Sheikh NA, Dreicer R. A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T. Cancer Immunol Res. 2014. 2:988-99

Mehta HM, Futami M, Glaubach T, Lee DW, Andolina JR, Yang Q, Whichard Z, Quinn M, Lu HF, Kao WM, Przychodzen B, Sarkar CA, Minella A, Maciejewski JP, Corey SJ. Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition. Leukemia. 2014 May;28(5):1041-51. doi: 10.1038/leu.2013.321. Epub 2013 Oct 30.

Mehta RS, Di Stasi A, Andersson BS, Nieto Y, Jones R, de Lima M, Hosing C, Popat U, Kebriaei P, Oran B, Alousi A, Rezvani K, Qazilbash M, Bashir Q, Bollard C, Cooper L, Worth L, Tewari P, McNiece I, Willhelm K, Champlin R, Shpall EJ. The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation. Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):e1-5. PMCID: PMC3913126

Mendese G, Maloney M, Bordeaux J. To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions. Dermatol Surg. 2014. 40:1077-83.

Meropol SB, Schiltz NK, Sattar A, Stange KC, Nevar AH, Davey C, Ferretti GA, Howell DE, Strosaker R, Vavrek P, Bader S, Ruhe MC, Cuttler L. Practice-tailored facilitation to improve pediatric preventive care delivery: a randomized trial. Pediatrics. 2014. 133:e1664-75.

Mester J, Eng C. Cowden syndrome: Recognizing and managing a not-so-rare hereditary cancer syndrome. J Surg Oncol. 2014 Aug 11. doi: 10.1002/jso.23735. [Epub ahead of print]

Meyers JD, Cheng Y, Broome AM, Agnes RS, Schluchter MD, Margevicius S, Wang X, Kenney ME, Burda C, Basilion J. Peptide-targeted gold nanoparticles for photodynamic therapy of brain cancer. 2014. In Press

Miao H, Gale NW, Guo H, Qian J, Petty A, Kaspar J, Murphy AJ, Valenzuela DM, Yancopoulos G, Hambardzumyan D, Lathia JD, Rich JN, Lee J, Wang B. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties. Oncogene. 2014 Feb 3. In press

Micucci JA, Layman WS, Hurd EA, Sperry ED, Frank SF, Durham MA, Swiderski DL, Skidmore JM, Scacheri PC, Raphael Y, Martin DM. CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome. Hum Mol Genet. 2014 Jan 15;23(2):434-48. PMCID: PMC3869363

Miller VA, Baker JN, Leek AC, Drotar D, Kodish E. Patient involvement in informed consent for pediatric phase I cancer research. J Pediatr Hematol Oncol. 2014. 36:635-40.

Miller VA, Cousino M, Leek AC, Kodish ED. Hope and persuasion by physicians during informed consent. J Clin Oncol. 2014. 32:3229-35.

Minca EC, Lanigan CP, Reynolds JP, Wang Z, Ma PC, Cicenia J, Almeida FA, Pennell NA, Tubbs RR. ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material. J Thorac Oncol. 2014 Apr;9(4):464-8. doi: 10.1097/JTO.0000000000000104.

Mir MC, Autorino R, Samarasekera D, Klink J, Stephenson AJ, Kaouk JH Robot-assisted laparoscopic retroperitoneal lymph node dissection for left clinical stage I non-seminomatous germ cell testicular cancer: Focus on port placement and surgical technique. Int J Urol. 2014 Feb;21(2):212-4.

Mislmani M, Frasure H, Suppiah S, Fabien J, Lo SS, Debernardo R, Kunos CA. Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignancies. Future Oncol. 2014 Feb;10(2):241-8.

Mittal K, Ebos J, Rini B. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. Semin Oncol. 2014 Apr;41(2):235-51. doi: 10.1053/j.seminoncol.2014.02.007. Epub 2014 Feb 28. Review.

Mittal K, Koon H, Elson P, Triozzi P, Dowlati A, Chen H, Borden EC, Rini BI. Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers. Cancer Biol Ther. 2014. 15:975-81.

Mittal K, McNamara MJ, Curtis BR, McCrae KR. Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia. JRSM Open. 2014 Jun;5(6):2054270414531126. doi: 10.1177/2054270414531126.

Modery-Pawlowski CL, Sen Gupta A. Heteromultivalent ligand-decoration for actively targeted nanomedicine. Biomaterials. 2014 Jan 8. In press

Mohammadi AM, Hawasli AH, Rodriguez A, Schroeder JL, Laxton AW, Elson P, Tatter SB, Barnett GH, Leuthardt EC. The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Cancer Med. 2014 May 9. doi: 10.1002/cam4.266. [Epub ahead of print]

Mohammadi AM, Sullivan TB, Barnett GH, Recinos V, Angelov L, Kamian K, Vogelbaum MA. Use of high-field intra-operative Magnetic Resonance Imaging to enhance the extent of resection of enhancing and non-enhancing gliomas. Neurosurgery. 2014. In press

Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Mol Cancer. 2014 May 31;13(1):132. doi: 10.1186/1476-4598-13-132.

Moline J, Eng C. Equality in Lynch Syndrome Screening: Why Should We Hold Patients With Endometrial Cancer to a Different Standard? Ann Oncol. 2014 Jun 8. doi:pii: mdu212. [Epub ahead of print]

Moore LR, Williams PS, Nehl F, Abe K, Chalmers JJ, Zborowski M. Feasibility study of red blood cell debulking by magnetic field-flow fractionation with step-programmed flow. Anal Bioanal Chem. 2014 In press

Morton ML, Bai X, Merry CR, Linden PA, Khalil AM, Leidner RS, Thompson CL. Identification of mRNAs and lincRNAs associated with lung cancer progression using next-generation RNA sequencing from laser micro-dissected archival FFPE tissue specimens. Lung Cancer. 2014 Jul;85(1):31-9. doi: 10.1016/j.lungcan.2014.03.020. Epub 2014 Mar 29.

Mukherjee S, Boccaccio D, Sekeres MA, Copelan E. Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Lingering Uncertainties and Emerging Possibilities. Biol Blood Marrow Transplant. 2014 Jul 29. doi:pii: S1083-8791(14)00477-7.  10.1016/j.bbmt.2014.07.027. [Epub ahead of print] Review.

Mukherjee S, Reddy CA, Ciezki JP, Abdel-Wahab M, Tiu RV, Copelan E, Advani AA, Saunthararajah Y, Paulic K, Hobson S, Maciejewski JP, Bolwell BJ, Kalaycio M, Dreicer R, Klein EA, Sekeres MA. Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation. J Natl Cancer Inst. 2014 Mar;106(3):djt462. doi: 10.1093/jnci/djt462. Epub 2014 Feb 27.

Mukhopadhyay S, Pennell NA, Ali SM, Ross JS, Ma PC, Velcheti V. RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib. J Thorac Oncol. 2014. 9:1714-9

Mutter GL, Monte NM, Neuberg D, Ferenczy A, Eng C. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues. Cancer Res. 2014 May 15;74(10):2796-802. doi: 10.1158/0008-5472.CAN-14-0108. Epub 2014 Mar 24.

Najjar YG, Mittal K, Elson P, Wood L, Garcia JA, Dreicer R, Rini BI. A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma. Eur J Cancer. 2014. 50:1084-9.

Nakashima MO, Shetty S, Chicka M, Flagg A, Eng C, Cotta CV. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations. Pediatr Blood Cancer. 2014 Aug 30. doi: 10.1002/pbc.25226. [Epub ahead of print]

Narayan S, Flask CA, Kalhan SC, Wilson DL. Hepatic fat during fasting and refeeding by MRI fat quantification. J Magn Reson Imaging. 2014. In Press

Navaneethan U, Lourdusamy V, Gk Venkatesh P, Willard B, Sanaka MR, Parsi MA. Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study. Gastroenterol Rep (Oxf). 2014.in press

Nawrocki ST, Kelly KR, Smith PG, Keaton M, Carraway H, Sekeres MA, Maciejewski JP, Carew JS. The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine. Clin Cancer Res. 2014. in press

Ngeow J, Eng C. TERT and BRAF in Thyroid Cancer: Teaming Up for Trouble. J Clin Oncol. 2014 Sep 1;32(25):2683-4. doi: 10.1200/JCO.2014.56.5614. Epub 2014 Jul 14. No abstract available.

Ngeow J, Ni Y, Tohme R, Song Chen F, Bebek G, Eng C. Germline Alterations in RASAL1 in Cowden Syndrome Patients Presenting with Follicular Thyroid Cancer and in Individuals with Apparently Sporadic Epithelial Thyroid Cancer. J Clin Endocrinol Metab. 2014 Apr 8:jc20141225. [Epub ahead of print]

Ngeow J, Stanuch K, Mester JL, Barnholtz-Sloan JS, Eng C. Second Malignant Neoplasms in Patients With Cowden Syndrome With Underlying Germline PTEN Mutations. J Clin Oncol. 2014 Jun 10;32(17):1818-24. doi: 10.1200/JCO.2013.53.6656. Epub 2014 Apr 28.

Nickolich M, Babakoohi S, Fu P, Dowlati A. Clinical trial design in small cell lung cancer: Surrogate end points and statistical evolution. Clin Lung Cancer. 2014 In press

Nock NL, Dimitropoulos A, Rao SM, Flask CA, Schluchter M, Zanotti KM, Rose PG, Kirwan JP, Alberts J. Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors. Contemp Clin Trials. 2014. 39:236-45.

Norris RE, Adamson PC, Nguyen VT, Fox E. Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors. Pediatr Blood Cancer. 2014 Jan;61(1):145-50. PMCID: PMC3849815

Norris RE, Nguyen VT, Adamson PC. Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastoma. J Pediatr Hematol Oncol. 2014 Jan;36(1):e23-7. PMCID: PMC3766379

Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects. Cancer Causes Control. 2014. In Press

Ochs-Balcom HM, Cannioto R, Nie J, Millen AE, Freudenheim JL, Chen Z, Thompson CL, Tracy R, Li L. Adipokines do not mediate the association of obesity and colorectal adenoma. J Cancer Epidemiol. 2014;2014:371254. doi: 10.1155/2014/371254. Epub 2014 Aug 13.

Ochs-Balcom HM, Sun X, Chen Y, Barnholtz-Sloan JS, Erwin DO, Jandorf L, Sucheston-Campbell LE, Elston RC. Putative linkage signals identified for breast cancer in African American families. Cancer Epidemiol Biomarkers Prev. 2014. In Press

Odom BD, Mir MC, Hughes S, Senechal C, Santy A, Eyraud R, Stephenson AJ, Ylitalo K, Miocinovic R. Active surveillance for low-risk prostate cancer in African American men: A multi-institutional experience. Urology. 2014 Feb;83(2):364-8.

Ok CY, Chen J, Xu-Monette ZY, Tzankov A, Manyam GC, Li L, Visco C, Montes-Moreno S, Dybkí_r K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Zhao X, Ponzoni M, Ferreri AJ, Bertoni F, et al. Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2014 Aug 14. [Epub ahead of print]

Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fossay SD, GermaÊ-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Tandstad T. Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol. 2014. in press

Ondrejka SL, Jegalian AG, Kim AS, Chabot-Richards DS, Giltnane J, Czuchlewski DR, Shetty S, Sekeres MA, Yenamandra A, Head D, Jagasia M, Hsi ED. PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: The missing link supporting a stem cell origin. Haematologica. 2014 Jun 20. doi:pii: haematol.2014.105452. [Epub ahead of print]

Ornstein MC, Mukherjee S, Mohan S, Elson P, Tiu RV, Saunthararajah Y, Kendeigh C, Advani A, Kalaycio M, Maciejewski JP, Sekeres MA. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia. Am J Hematol. 2014. ;89:168-73.

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS. The epidemiology of glioma in adults: a state of the science" review." Neuro Oncol. 2014 May 19. doi:pii: nou087. [Epub ahead of print] Review.

Ostrom QT, Chen Y, M de Blank P, Ondracek A, Farah P, Gittleman H, Wolinsky Y, Kruchko C, Cohen ML, Brat DJ, Barnholtz-Sloan JS. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010. Neuro Oncol. 2014. 16:1392-9.

Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol. 2014. 16 Suppl 4:iv1-iv63.

Ouyang Z, Chen Z, Ishikawa M, Yue X, Kawanami A, Leahy P, Greenfield EM, Murakami S. Prx1 and 3.2kb Col1a1 promoters target distinct bone cell populations in transgenic mice. Bone 2014 Jan 58:136–145

Ouzaid I, Autorino R, Fatica R, Herts BR, McLennan G, Remer EM, Haber GP. Active surveillance for renal angiomyolipoma: Outcomes and predictive factors of delayed intervention. BJU Int. 2014 In press

Ouzaid I, Rini B. Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma. Eur Urol. 2014 Mar;65(3):667-8. doi: 10.1016/j.eururo.2013.11.023. No abstract available.

Padron E, Yoder S, Kunigal S, Mesa T, Teer JK, Al Ali N, Sekeres MA, Painter JS, Zhang L, Lancet J, Maciejewski JP, Epling-Burnette PK, Sotomayor E, Komrokji RS, List AF. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Cell Stem Cell. 2014 Jun 5;14(6):854-63. doi: 10.1016/j.stem.2014.05.005.

Palathinkal DM, Sharma TR, Koon HB, Bordeaux JS. Current systemic therapies for melanoma. Dermatol Surg. 2014 Sep;40(9):948-63. doi: 10.1097/01.DSS.0000452626.09513.55.

Paly JJ, Hallemeier CL, Biggs PJ, Niemierko A, Roeder F, Martínez-Monge R, Whitson J, Calvo FA, Fastner G, Sedlmayer F, Wong WW, Ellis RJ, Haddock MG, Choo R, Shipley WU, Zietman AL, Efstathiou JA. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 Jan 8 In press

Pandita A, Mukherjee S. Resuscitating a dying marrow: the role of hematopoietic growth factors. Curr Hematol Malig Rep. 2014. 9:412-20.

Papp-Wallace KM, Mallo S, Bethel CR, Taracila MA, Hujer AM, Fernández A, Gatta JA, Smith KM, Xu Y, Page MG, Desarbre E, Bou G, Bonomo RA. A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems. J Antimicrob Chemother. 2014 69(3):682-690.

Parikh A, Lee C, Joseph P, Marchini S, Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, Mullokandov G, Fishman D, D'Incalci M, Rahaman J, Kalir T, Redline RW, Brown BD, Narla G, Difeo A. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun. 2014 Jan 7;5:2977. PMCID: PMC3896774

Parilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Oncologist. 2014 Jun 4. doi:pii: theoncologist.2014-0056. [Epub ahead of print] Review.

Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol. 2014. 192:1081-7.

Partovi S, Kohan A, Rubbert C, Vercher-Conejero JL, Gaeta C, Yuh R, Zipp L, Herrmann KA, Robbin MR, Lee Z, Muzic RF Jr, Faulhaber P, Ros PR. Clinical oncologic applications of PET/MRI: a new horizon. Am J Nucl Med Mol Imaging. 2014;4(2):202-212. Review.

Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR. Qualitative and Quantitative Performance of 18F-FDG-PET/MRI versus 18F-FDG-PET/CT in Patients with Head and Neck Cancer. AJNR Am J Neuroradiol. 2014. 35:1970-5.

Partovi S, Kohan AA, Zipp L, Faulhaber P, Kosmas C, Ros PR, Robbin MR. Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials. Int J Clin Exp Med. 2014;7(3):640-8.

Partovi S, Robbin MR, Steinbach OC, Kohan A, Rubbert C, Vercher-Conejero JL, Kolthammer JA, Faulhaber P, Paspulati RM, Ros PR. Initial experience of MR/PET in a clinical cancer center. J Magn Reson Imaging. 2014 Apr;39(4):768-80. doi: 10.1002/jmri.24334. Epub 2013 Sep 4.

Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O'Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Clin Oncol. 2014 Jan 10;32(2):129-60.

Peereboom DM, Murphy C, Ahluwalia MS, Conlin A, Eichler A, Van Poznak C, Baar J, Elson P, Seidman AD. Phase II trial of patupilone in patients with brain metastases from breast cancer Neuro Oncol. 2014. 16:579-83. PMCID: PMC3956359

Peiris PM, Tam M, Vicente P, Abramowski A, Toy R, Bauer L, Mayer A, Pansky J, Doolittle E, Tucci S, Schmidt E, Shoup C, Rao S, Murray K, Gopalakrishnan R, Keri RA, Basilion JP, Griswold MA, Karathanasis E. On-command drug release from nanochains inhibits growth of breast tumors. Pharm Res. 2014. 31:1460-8. PMCID: PMC3875625

Peiris PM, Toy R, Abramowski A, Vicente P, Tucci S, Bauer L, Mayer A, Tam M, Doolittle E, Pansky J, Tran E, Lin D, Schiemann WP, Ghaghada KB, Griswold MA, Karathanasis E. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J Control Release. 2014 Jan 10;173:51-8. PMCID:PMC3873646

Pemmaraju N, Shah D, Kantarjian H, Orlowski RZ, Nogueras Gonzíçlez GM, Baladandayuthapani V, Jain N, Wagner V, Garcia-Manero G, Shah J, Ravandi F, Pierce S, Takahashi K, Daver N, Nazha A, Verstovsek S, Jabbour E, De Lima M, Champlin R, Cortes J, Qazilbash MH. Characteristics and Outcomes of Patients With Multiple Myeloma Who Develop Therapy-Related Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2014 Jul 15. doi:pii: S2152-2650(14)00261-4.  10.1016/j.clml.2014.07.001. [Epub ahead of print]

Peppercorn J, Zafar SY, Houck K, Ubel P, Meropol NJ. Does comparative effectiveness research promote rationing of cancer care? Lancet Oncol. 2014 Mar;15(3):e132-8. doi: 10.1016/S1470-2045(13)70597-7. Epub 2014 Feb 14.

Pereira GC, Traughber M, Muzic RF Jr. The role of imaging in radiation therapy planning: past, present, and future. Biomed Res Int. 2014;2014:231090. doi: 10.1155/2014/231090. Epub 2014 Apr 10.

Perera RH, Solorio L, Wu H, Gangolli M, Silverman E, Hernandez C, Peiris PM, Broome AM, Exner AA. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation. Pharm Res. 2014 In press

Perera VS, Yang LD, Hao J, Chen G, Erokwu BO, Flask CA, Zavalij PY, Basilion JP, Huang SD. Biocompatible Nanoparticles of KGd(H2O)2[Fe(CN)6]·H2O with Extremely High T1-Weighted Relaxivity Owing to Two Water Molecules Directly Bound to the Gd(III) Center Langmuir. 2014. In Press

Phillips-Mason PJ, Craig SE, Brady-Kalnay SM. A Protease Storm Cleaves a Cell-Cell Adhesion Molecule in Cancer: Multiple Proteases Converge to Regulate PTPmu in Glioma Cells. J Cell Biochem. 2014 Apr 28. doi: 10.1002/jcb.24824. [Epub ahead of print]

Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viína M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J,  Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C Non-permissive -DPB1 mismatch among otherwise HLA-matched donor-recipient pairs results in increased overall mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation for hematologic malignancies. Blood. 2014 Aug 26. doi:pii: blood-2014-05-576041. [Epub ahead of print]

Pierre EY, Grodzki D, Heismann B, Aandal G, Gulani V, Sunshine J, Schluchter M, Liu K, Griswold M. Parallel imaging-based reduction of acoustic noise for clinical magnetic resonance imaging 2014. In Press

Platzbecker U, Sekeres MA, Kantarjian H, Giagounidis A, Mufti GJ, Jia C, Yang AS, Fenaux P. Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial. Leukemia. 2014 Sep 2. doi: 10.1038/leu.2014.253. [Epub ahead of print] No abstract available.

Plecha D, Salem N, Kremer M, Pham R, Downs-Holmes C, Sattar A, Lyons J. Neglecting to screen women between 40 and 49 years old with mammography: what is the impact on treatment morbidity and potential risk reduction? AJR Am J Roentgenol. 2014 Feb;202(2):282-8. doi: 10.2214/AJR.13.11382.

Plecha DM, Pham RM, Klein N, Coffey A, Sattar A, Marshall H. Addition of Shear-Wave Elastography during Second-Look MR Imaging-directed Breast US: Effect on Lesion Detection and Biopsy Targeting. Radiology. 2014. 272:657-64.

Plow EF, Meller J, Byzova TV. Integrin function in vascular biology: a view from 2013. Curr Opin Hematol. 2014 May;21(3):241-7. doi: 10.1097/MOH.0000000000000042.

Ponsky DC, Schmitt AR, Stepnick DW, Bordeaux JS. Access and surgical approach to the isolated intranasal basal cell carcinoma. Br J Dermatol. 2014  In press

Portell CA, Advani AS. Novel targeted therapies in acute lymphoblastic leukemia. Leuk Lymphoma. 2014 Apr;55(4):737-48. doi: 10.3109/10428194.2013.823493. Epub 2013 Aug 28.

Portell CA, Aronow ME, Rybicki LA, Macklis R, Singh AD, Sweetenham JW. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype. Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):203-10. doi: 10.1016/j.clml.2013.10.011. Epub 2013 Nov 15.

Powazki R, Walsh D, Cothren B, Rybicki L, Thomas S, Morgan G, Karius D, Davis MP, Shrotriya S. The care of the actively dying in an academic medical center: A survey of registered nurses' professional capability and comfort. Am J Hosp Palliat Care. 2014 In press

Qi P, Pouliot J, Roach M 3rd, Xia P. Offline multiple adaptive planning strategy for concurrent irradiation of the prostate and pelvic lymph nodes. Med Phys. 2014 Feb;41(2):021704.

Qin A, Thompson CL, Silverman P. Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin. J Cancer Surviv. 2014. in press

Qing Y, Wang Z, Bunting KD, Gerson SL. Bcl2 overexpression rescues the hematopoietic stem cell defects in Ku70-deficient mice by restoration of quiescence. Blood. 2014. 23:1002-11 (PMC3924923)

R, Rayman P, Cohen PA, Finke JH, Tuohy VK. Jaini Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy. Int J Cancer. 2014 Apr 1;134(7):1695-705.

Radivoyevitch T, Jankovic GM, Tiu RV, Saunthararajah Y, Jackson RC, Hlatky LR, Gale RP, Sachs RK. Sex differences in the incidence of chronic myeloid leukemia. Radiat Environ Biophys. 2014 Mar;53(1):55-63. doi: 10.1007/s00411-013-0507-4. Epub 2013 Dec 13.

Radivoyevitch T, Saunthararajah Y. Sex difference in myelodysplastic syndrome survival and balance in randomized clinical trials. J Clin Oncol. 2014 Jan 1;32(1):60-1.

Raigani S, Ammori J, Kim J, Hardacre JM. Trends in the treatment of resectable pancreatic adenocarcinoma. J Gastrointest Surg. 2014 Jan;18(1):113-23.

Raigani S, Hardacre JM, Kim J, Ammori JB. Trends in the surgical treatment of gastric adenocarcinoma. Ann Surg Oncol. 2014 In press.

Rajala HL, Olson T, Clemente MJ, Lagstram S, Ellonen P, Lundan T, Hamm DE, Uz Zaman SA, Lopez Marti JM, Andersson EI, Jerez A, Porkka K, Maciejewski JP, Loughran TP, Mustjoki S. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Haematologica. 2014. in press

Ramello MC, Tosello Boari J, Canale FP, Mena HA, Negrotto S, Gastman B, Gruppi A, Acosta Rodraguez EV, Montes CL. Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. Cell Death Dis. 2014. 5:e1507.

Randhawa JS, Budd GT, Randhawa M, Ahluwalia M, Jia X, Daw H, Spiro T, Haddad A. Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience. Am J Clin Oncol. 2014. In Press

Razorenova OV, Castellini L, Colavitti R, Edgington LE, Nicolau M, Huang X, Bedogni B, Mills EM, Bogyo M, Giaccia AJ. The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells. Mol Cell Biol. 2014 Feb;34(4):739-51.

Reynolds JP, Tubbs RR, Minca EC, MacNamara S, Almeida FA, Ma PC, Pennell NA, Cicenia JC EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC). Lung Cancer. 2014. 86:158-63.

Richardson BS, Anderson WF, Barnholtz-Sloan JS, Tucker MA, Gerstenblith MR. The Age-Specific Effect Modification of Male Sex for Ulcerated Cutaneous Melanoma. JAMA Dermatol. 2014 Mar 5. doi: 10.1001/jamadermatol.2013.7127. [Epub ahead of print]

Rieder F, Nonevski I, Ma J, Ouyang Z, West G, Protheroe C, Depetris G, Schirbel A, Lapinski J, Goldblum J, Bonfield T, Lopez R, Harnett K, Lee J, Hirano I, Falk G, Biancani P, Fiocchi C. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. Gastroenterology. 2014 Jan 28. In press

Riffe MJ, Yutzy SR, Jiang Y, Twieg MD, Blumenthal CJ, Hsu DP, Pan L, Gilson WD, Sunshine JL, Flask CA, Duerk JL, Nakamoto D, Gulani V, Griswold MA. Device localization and dynamic scan plane selection using a wireless magnetic resonance imaging detector array. Magn Reson Med. 2014. 71:2243-9.

Ringdíen O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani BN, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS. Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning. Biol Blood Marrow Transplant. 2014 Jul 17. doi:pii: S1083-8791(14)00435-2.  10.1016/j.bbmt.2014.07.009. [Epub ahead of print]

Ringdon O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, et al. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant. 2014. 20:1777-84.

Rini B, Redman B, Garcia JA, Burris HA 3rd, Li S, Fandi A, Beck R, Jungnelius U, Infante JR. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer. Stat Methods Med Res. 2014 Jun 11. doi:pii: 0962280214537390. [Epub ahead of print]

Rini BI, Bellmunt J, Clancy J, Wang K, Niethammer AG, Hariharan S, Escudier B. Randomized Phase III trial of Temsirolimus and Bevacizumab versus Interferon Alfa and Bevacizumab in metastatic renal cell carcinoma: INTORACT Trial. J Clin Oncol. 2014 In press

Rini BI, Quinn DI, Baum M, Wood LS, Tarazi J, Rosbrook B, Arruda LS, Cisar L, Roberts WG, Kim S, Motzer RJ. Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial. Target Oncol. 2014 Mar 5. [Epub ahead of print]

Rose J, Augestad KM, Cooper GS. Colorectal cancer surveillance: what's new and what's next. World J Gastroenterol. 2014. 20:1887-97.

Rose J, Augestad KM, Kong CY, Meropol NJ, Kattan MW, Hong Q, An X, Cooper GS. A simulation model of colorectal cancer surveillance and recurrence. BMC Med Inform Decis Mak. 2014 Apr 8;14:29. doi: 10.1186/1472-6947-14-29.

Rose PG, Java JJ, Whitney CW, Stehman FB, Lanciano R, Thomas GM. Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-based chemoradiation. Gynecol Oncol. 2014 Aug 23. doi:pii: S0090-8258(14)01271-2.  10.1016/j.ygyno.2014.08.018. [Epub ahead of print]

Rose PG, Metz C, Link N. Desensitization with oxaliplatin in patients intolerant of Carboplatin desensitization. Int J Gynecol Cancer. 2014.24:1603-6.

Rose PG. Using Positron Emission Tomography imaging for maximum benefit in locally advanced cervical cancer. J Clin Oncol. 2014 Feb 1;32(4):357-8.

Rosko AE, Corriveau M, Suwantarat N, Arfons L, Treasure M, Parker P, Jacobs M, Fu P, Salata R, Lazarus HM. Vancomycin-Resistant Enterococci (VRE) infection: Not just for the transplanted. Leuk Lymphoma. 2014 In press

Rusu M, Bloch BN, Jaffe CC, Genega EM, Lenkinski RE, Rofsky NM, Feleppa E, Madabhushi A. Prostatome: a combined anatomical and disease based MRI atlas of the prostate. Med Phys. 2014. 41:072301.

Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS. Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and M Biol Blood Marrow Transplant. 2014. 20:1566-72.

Sabloff M, Sobecks RM, Ahn KW, Zhu X, de Lima M, Brown JR, Inamoto Y, Holland HK, Aljurf MD, Laughlin MJ, Kamble RT, Hsu JW, Wirk BM, Seftel M, Lewis ID, Arora M, Alyea EP, Kalaycio ME, Cortes J, Maziarz RT, Gale RP, Saber W. Does total body irradiation conditioning improve outcomes of myeloablative HLA-identical sibling transplants for Chronic Lymphocytic Leukemia? Biol Blood Marrow Transplant. 2014 In press

Sadraei NH, Dahiya S, Chao ST, Murphy ES, Osei-Boateng K, Xie H, Suh JH, Peereboom DM, Stevens GH, Ahluwalia MS. Treatment of cerebral radiation necrosis with bevacizumab: The Cleveland Clinic Experience. Am J Clin Oncol. 2014 In press.

Sahoo SS, Tao S, Parchman A, Luo Z, Cui L, Mergler P, Lanese R, Barnholtz-Sloan JS, Meropol NJ, Zhang GQ. Trial prospector: matching patients with cancer research studies using an automated and scalable approach. Cancer Inform. 2014. 13:157-66.

Salem ME, Shah SN, Elson P, Garcia JA, Wood LS, Medsinge A, Campbell S, Dreicer R, Rini BI. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib. Clin Genitourin Cancer. 2014. 12:117-23.

Samala RV, Bloise R, Davis MP. Efficacy and safety of a six hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain. J Pain Symptom Manage. 2014 In press

Sayed A, Layne G, Abraham J, Mukdadi OM. 3-D Visualization and Non-linear Tissue Classification of Breast Tumors Using Ultrasound Elastography InåÊVivo. Ultrasound Med Biol. 2014 Jul;40(7):1490-502. doi: 10.1016/j.ultrasmedbio.2014.02.002. Epub 2014 Apr 24.

Schmaier AH. Extracorporeal circulation without bleeding. Sci Transl Med. 2014 Feb 5;6(222):222fs7.

Schmitt AR, Brewer JD, Bordeaux JS, Baum CL. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: Meta-analysis of American Joint Committee on Cancer Criteria and a Proposed Alternative System. JAMA Dermatol. 2014 Jan 1;150(1):19-24.

Schnipper LE, Meropol NJ. Payment for Cancer Care: Time for a New Prescription. J Clin Oncol. 2014. in press

Schomisch SJ, Yu L, Wu Y, Pauli EM, Cipriano C, Chak A, Lash RH, Ponsky JL, Marks JM. Commercially available biological mesh does not prevent stricture after esophageal mucosectomy. Endoscopy. 2014 Feb;46(2):144-8.

Schonberg DL, Lubelski D, Miller TE, Rich JN. Brain tumor stem cells: Molecular characteristics and their impact on therapy. Mol Aspects Med. 2014. 39:82-101.

Schutz FA, Xie W, Donskov F, Sircar M, McDermott DF, Rini BI, Agarwal N, Pal SK, Srinivas S, Kollmannsberger C, North SA, Wood LA, Vaishampayan U, Tan MH, Mackenzie MJ, Lee JL, Rha SY, Yuasa T, Heng DY, Choueiri TK. The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium. Eur Urol. 2014 Apr;65(4):723-30. doi: 10.1016/j.eururo.2013.10.013. Epub 2013 Oct 26.

Schwandt A, von Gruenigen VE, Wenham RM, Frasure H, Eaton S, Fusco N, Fu P, Wright JJ, Dowlati A, Waggoner S. Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer. Invest New Drugs. 2014 Mar 12. [Epub ahead of print]

Scott A, Song J, Ewing R, Wang Z. Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications. Acta Biochim Biophys Sin (Shanghai). 2014 Jan 3. In press

Seastone DJ, Elson P, Garcia JA, Chao ST, Suh JH, Angelov L, Rini BI. Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma. Clin Genitourin Cancer. 2014. 12:111-6.

Sekeres MA, Giagounidis A, Kantarjian H, Mufti GJ, Fenaux P, Jia C, Yang AS, Platzbecker U. Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes. Br J Haematol. 2014. 167:337-45.

Sekeres MA. The Puzzle of Cancer Recovery. J Clin Oncol. 2014 Aug 4. doi:pii: JCO.2014.57.5233. [Epub ahead of print] No abstract available.

Senese S, Lo YC, Huang D, Zangle TA, Gholkar AA, Robert L, Homet B, Ribas A, Summers MK, Teitell MA, Damoiseaux R, Torres JZ. Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death Dis. 2014. 5:e1462.

Sereti I, Estes JD, Thompson WL, Morcock DR, Fischl MA, Croughs T, Beq S, Lafaye de Micheaux S, Yao MD, Ober A, Wilson EM, Natarajan V, Imamichi H, Boulassel MR, Lederman MM, Routy JP. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014 Jan 30;10(1):e1003890.

Shabb NS, Boulos FI, Chakhachiro Z, Abbas J, Abdul-Karim FW. Inconclusive or erroneous fine-needle aspirates of breast with adequate and representative material: A Cytologic/Histologic Study. Diagn Cytopathol. 2014 In press

Sharifi N, Auchus RJ. Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter. Clin Cancer Res. 2014. 20:4971.

Sharma A, Janocha AJ, Hill BT, Smith MR, Erzurum SC, Almasan A. Targeting mTORC1-Mediated Metabolic Addiction Overcomes Fludarabine Resistance in Malignant B Cells. Mol Cancer Res. 2014 Jul 24. [Epub ahead of print]

Sharma H, Kanwal R, Bhaskaran N, Gupta S. Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells. PLoS One. 2014;9(3):e91588. doi: 10.1371/journal.pone.0091588.

Sharma M, Zhang MJ, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, Klumpp TR, Krishnan AY, Landau HJ, Lazarus HM, Lonial S, Maiolino A, Marks DI, et al. Older patients with myeloma derive similar benefit from autologous transplantation. Biol Blood Marrow Transplant. 2014. 20:1796-803.

Sharma N, Pennell N, Nickolich M, Halmos B, Ma P, Mekhail T, Fu P, Dowlati A. Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer. Invest New Drugs. 2014 Apr;32(2):362-8. doi: 10.1007/s10637-013-0061-6. Epub 2014 Jan 15.

Shaverdashvili K, Wong P, Ma J, Zhang K, Osman I, Bedogni B. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1. Pigment Cell Melanoma Res. 2014 Mar;27(2):287-96. doi: 10.1111/pcmr.12201. Epub 2014 Jan 6.

Shaw PJ, Nath CE, Lazarus HM. Not too little, not too much-just right! (Better ways to give high dose melphalan). Bone Marrow Transplant. 2014 Aug 18. doi: 10.1038/bmt.2014.186. [Epub ahead of print]

Shinde S, Gordon P, Sharma P, Gross J, Davis MP. Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements? Support Care Cancer. 2014 Aug 29. [Epub ahead of print]

Shiue K, Barnett GH, Suh JH, Vogelbaum MA, Reddy CA, Weil RJ, Angelov L, Neyman G, Chao ST. Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective. Neurosurgery. 2014 Apr;74(4):360-4; discussion 364-5; quiz 365-6. doi: 10.1227/NEU.0000000000000289.

Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A, Martignoni G, Rini BI, Kutikov A. Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity. Eur Urol. 2014 May 20. doi:pii: S0302-2838(14)00410-2.  10.1016/j.eururo.2014.04.029. [Epub ahead of print] Review.

Shukla S, Bhaskaran N, Babcook MA, Fu P, Maclennan GT, Gupta S. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis. 2014 In press

Shukla S, Fu P, Gupta S. Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer. Apoptosis. 2014 May;19(5):883-94. doi: 10.1007/s10495-014-0971-6.

Shukla S, Wen AM, Ayat NR, Commandeur U, Gopalkrishnan R, Broome AM, Lozada KW, Keri RA, Steinmetz NF. Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice. Nanomedicine (Lond). 2014 In press.

Silverman RH, Weiss SR. Viral Phosphodiesterases That Antagonize Double-Stranded RNA Signaling to RNase L by Degrading 2-5A. Gynecol Oncol. 2014 Jun 3. doi:pii: S0090-8258(14)00984-6.  10.1016/j.ygyno.2014.05.024. [Epub ahead of print]

Singh K, Sharma A, Mir MC, Drazba JA, Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA, Almasan A. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Mol Cancer. 2014 Mar 23;13:70. doi: 10.1186/1476-4598-13-70.

Singh V, Gupta D, Arora R, Tripathi RP, Almasan A, Macklis RM. Surface Levels of CD20 Determine Anti-CD20 Antibodies Mediated Cell Death In Vitro. PLoS One. 2014. 9:e111113.

Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer TC, Tismenetsky M, Tsui CL, Friedlander PA, Parides MK, Banchereau J, Chaussabel D, Lebwohl MG, Wolchok JD, Bhardwaj N, Burakoff SJ, Oh WK, Palucka K, Merad M, Schadt EE, Saenger YM. Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease. J Invest Dermatol. 2014. 134:2202-11.

Sizemore GM, Sizemore ST, Seachrist DD, Keri RA. GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2). J Biol Chem. 2014. 289:24102-13. PMCID: PMC4148843

Sizemore ST, Sizemore GM, Booth CN, Thompson CL, Silverman P, Bebek G, Abdul-Karim FW, Avril S, Keri RA. Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Res Treat. 2014 Jul;146(1):25-40. doi: 10.1007/s10549-014-2989-4. Epub 2014 May 22.

Smith M, Mester J, Eng C. How to spot heritable breast cancer: A primary care physician's guide. Cleve Clin J Med. 2014 Jan;81(1):31-40.

Smith MR, Jin F, Joshi I. Milatuzumab and veltuzumab induce apoptosis through JNK signalling in an NF-κB dependent human transformed follicular lymphoma cell line. Br J Haematol. 2014 Jan 6.

Smith MR. Is early hematopoietic stem-cell transplantation necessary in mantle-cell lymphoma? J Clin Oncol. 2014 Feb 1;32(4):265-7.

Snow-Lisy DC, Campbell SC, Gill IS, Hernandez AV, Fergany A, Kaouk J, Haber GP. Robotic and laparoscopic radical cystectomy for bladder cancer: Long-term oncologic outcomes. Eur Urol. 2014 Jan;65(1):193-200.

Sobecks RM, Leis JF, Gale RP, Ahn KW, Zhu X, Sabloff M, de Lima M, Brown JR, Inamoto Y, Hale GA, Aljurf MD, Kamble RT, Hsu JW, Pavletic SZ, Wirk B, Seftel MD, Lewis ID, Alyea EP, Cortes J, Kalaycio ME, Maziarz RT, Saber W. Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Conditioning Regimens. Biochim Biophys Acta. 2014 May 28. doi:pii: S0304-419X(14)00049-3.  10.1016/j.bbcan.2014.05.004. [Epub ahead of print]

Sohal DP, Rice TW, Rybicki LA, Rodriguez CP, Videtic GM, Saxton JP, Murthy SC, Mason DP, Phillips BE, Tubbs RR, Plesec T, McNamara MJ, Ives DI, Bodmann JW, Adelstein DJ. Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials. Dis Esophagus. 2014 May 21. doi: 10.1111/dote.12241. [Epub ahead of print]

Sohal DP, Walsh RM, Ramanathan RK, Khorana AA. Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy. J Natl Cancer Inst. 2014 Mar;106(3):dju011. doi: 10.1093/jnci/dju011. Epub 2014 Feb 22.

Solinas P, Fujioka H, Radivoyevitch T, Tandler B, Hoppel CL. Aging Effects on oxidative phosphorylation in rat adrenocortical mitochondria. Mech Ageing Dev. 2014 Jan 30. In press

Soloviev DA, Hazen SL, Szpak D, Bledzka KM, Ballantyne CM, Plow EF, Pluskota E. Dual Role of the Leukocyte Integrin ë±Më_2 in Angiogenesis. J Immunol. 2014. 193:4712-21.

Sossey-Alaoui K, Pluskota E, Davuluri G, Bialkowska K, Das M, Szpak D, Lindner DJ, Downs-Kelly E, Thompson CL, Plow EF. Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis. FASEB J. 2014 Jan 27

Stechschulte LA, Wuescher L, Marino JS, Hill JW, Eng C, Hinds TD Jr. Glucocorticoid Receptor ë_ Stimulates Akt1 Growth Pathway by Attenuation of PTEN. J Biol Chem. 2014 Jun 20;289(25):17885-17894. Epub 2014 May 9.

Stephenson AJ, Eggener SE, Hernandez AV, Klein EA, Kattan MW, Wood DP Jr, Rabah DM, Eastham JA, Scardino PT. Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. Eur Urol. 2014 Apr;65(4):675-80. doi: 10.1016/j.eururo.2013.08.036. Epub 2013 Aug 27.

Stoffel EM, Eng C. Exome sequencing in familial colorectal cancer: searching for needles in haystacks. Gastroenterology. 2014 Sep;147(3):554-6. doi: 10.1053/j.gastro.2014.07.031. Epub 2014 Jul 27. No abstract available.

Su CA, Iida S, Abe T, Fairchild RL. Endogenous memory CD8 T cells directly mediate cardiac allograft rejection. Am J Transplant. 2014 Feb 6.

Sugihara T, Yasunaga H, Horiguchi H, Fujimura T, Fushimi K, Yu C, Kattan MW, Homma Y. Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series. Int J Clin Oncol. 2014 Jan 7. In press

Sugihara T, Yasunaga H, Horiguchi H, Matsuda S, Fushimi K, Kattan MW, Homma Y. Does mechanical bowel preparation ameliorate damage from rectal injury in radical prostatectomy? Analysis of 151 rectal injury cases. Int J Urol. 2014. 1:566-70.

Sugihara T, Yasunaga H, Horiguchi H, Matsui H, Fujimura T, Nishimatsu H, Fukuhara H, Kume H, Yu C, Kattan MW, Kiyohide F, Homma Y. Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012-2013. Cancer Sci. 2014 Sep 2. doi: 10.1111/cas.12523. [Epub ahead of print]

Sugihara T, Yasunaga H, Horiguchi H, Matsui H, Nishimatsu H, Nakagawa T, Fushimi K, Kattan MW, Homma Y. Comparison of Perioperative Outcomes including Severe Bladder Injury between Monopolar and Bipolar Transurethral Resection of Bladder Tumors: A Population Based Comparison. J Urol. 2014. 192:1355-9.

Sugihara T, Yu C, Kattan MW, Yasunaga H, Ihara H, Onozawa M, Hinotsu S, Akaza H. Long-term Survival of Extremely Advanced Prostate Cancer Patients Diagnosed with Prostate-specific Antigen over 500 ng/ml. Jpn J Clin Oncol. 2014. in press

Sukhdeo K, Koch CE, Miller TE, Zhou H, Rivera M, Yan K, Cepko CL, Lathia JD, Rich JN. The Lgr5 transgene is expressed specifically in glycinergic amacrine cells in the mouse retina. Exp Eye Res. 2014 Feb;119:106-10.

Sun GE, Wells BJ, Yip K, Zimmerman R, Raghavan D, Kattan MW, Kashyap SR. Gender-specific effects of oral hypoglycemic agents on cancer risk in Type 2 Diabetes Mellitus. Diabetes Obes Metab. 2014 Mar;16(3):276-83.

Sun X, Chandar AK, Elston R, Chak A. What we know and what we need to know about familial gastroesophageal reflux disease and Barrett's esophagus. Clin Gastroenterol Hepatol. 2014. 12:1664-6

Swegal W, Koyfman S, Scharpf J, Sindwani R, Greskovich J, Borden E, Burkey BB. Endoscopic and Open Surgical Approaches to Locally Advanced Sinonasal Melanoma: Comparing the Therapeutic Benefits. JAMA Otolaryngol Head Neck Surg. 2014 Jul 31. doi: 10.1001/jamaoto.2014.1321. [Epub ahead of print]

Tabarroki A, Visconte V, Rogers HJ, Sekeres MA, Samaras C, Lichtin A, Duong HK, Englehaupt R, Cinalli T, Dodd K, Desamito J, Rouphail B, Altman JK, Stein BL, Tiu RV. Clinical experiences with ruxolitinib in symptomatic MPN patients with chronic kidney disease. Leuk Lymphoma. 2014 Jan;55(1):213-6.

Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, Honda K, Cooper KD, Gerstenblith MR. Update on primary mucosal melanoma. J Am Acad Dermatol. 2014 May 6. doi:pii: S0190-9622(14)01265-1.  10.1016/j.jaad.2014.03.031. [Epub ahead of print] Review.

Taimur S, Askar M, Sobecks R, Rybicki L, Warshawsky I, Mossad S. Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant. Transpl Infect Dis. 2014 In press

Takagi T, Mir MC, Campbell RA, Sharma N, Remer EM, Li J, Demirjian S, Kaouk JH, Campbell SC. Predictors of precision of excision and reconstruction in partial nephrectomy. J Urol. 2014 In press

Tan AR, Dowlati A, Stein MN, Jones SF, Infante JR, Bendell J, Kane MP, Levinson KT, Suttle AB, Burris Iii HA. Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies. Br J Cancer. 2014 May 27;110(11):2647-54. doi: 10.1038/bjc.2014.233. Epub 2014 May 6.

Tan M, Ye Z, Lindner D, Brady-Kalnay SM, Lu ZR. Synthesis and Evaluation of a Targeted Nanoglobular Dual-Modal Imaging Agent for MR Imaging and Image-Guided Surgery of Prostate Cancer. Pharm Res. 2014 Jun;31(6):1469-76. doi: 10.1007/s11095-013-1008-5. Epub 2013 Mar 8.

Tan MH, Eng C. RE: Cowden Syndrome and PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. Blood. 2014 Jun 5;123(23):3675-7. doi: 10.1182/blood-2014-03-562637. No abstract available.

Tavadze M, Rybicki L, Mossad S, Avery R, Yurch M, Pohlman B, Duong H, Dean R, Hill B, Andresen S, Hanna R, Majhail N, Copelan E, Bolwell B, Kalaycio M, Sobecks R. Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014. 49:1310-6.

Tenorio AR, Zheng Y, Bosch RJ, Krishnan S, Rodriguez B, Hunt PW, Plants J, Seth A, Wilson CC, Deeks SG, Lederman MM, Landay AL. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014. ;210:1248-59.

Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014. 23:1985-96.

Thakur VS, Deb G, Babcook MA, Gupta S. Plant phytochemicals as epigenetic modulators: Role in cancer chemoprevention. AAPS J. 2014. 16:151-63.

Thompson CL, Owusu C, Nock NL, Li L, Berger NA. Race, age, and obesity disparities in adult physical activity levels in breast cancer patients and controls. Front Public Health. 2014. 2:150

Tilot AK, Gaugler MK, Yu Q, Romigh T, Yu W, Miller RH, Frazier TW 2nd, Eng C. Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production. Hum Mol Genet. 2014 Jun 15;23(12):3212-27. doi: 10.1093/hmg/ddu031. Epub 2014 Jan 26.

Tiu RV, Sekeres MA. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes. Curr Opin Hematol. 2014 Mar;21(2):131-40. doi: 10.1097/MOH.0000000000000021.

Tiwari P, Danish S, Madabhushi A. Identifying MRI markers to evaluate early treatment related changes post laser ablation for cancer pain management. Proc SPIE. 2014 Mar 12;9036:90362L.

Tomsik PE, Witt AM, Raddock ML, DeGolia P, Werner JJ, Zyzanski SJ, Stange KC, Lawson PJ, Mason MJ, Smith S, Flocke SA. How well do physician and patient visit priorities align? J Fam Pract. 2014 Aug;63(8):E8-E13.

Torien J, RingdÌen O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M. Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. J Urol. 2014 May 31. doi:pii: S0022-5347(14)03712-4.  10.1016/j.juro.2014.05.100. [Epub ahead of print]

Toth R, Traughber B, Ellis R, Kurhanewicz J, Madabhushi A. A Domain Constrained Deformable (DoCD) Model for Co-registration of Pre- and Post-Radiated Prostate MRI. Neurocomputing. 2014 Nov 20;114:3-12.

Toth RJ, Shih N, Tomaszewski JE, Feldman MD, Kutter O, Yu DN, Paulus JC Jr, Paladini G, Madabhushi A. Histostitcher™: An informatics software platform for reconstructing whole-mount prostate histology using the extensible imaging platform framework. J Pathol Inform. 2014. 5:8. PMCID: PMC4023035

Toy R, Bauer L, Hoimes C, Ghaghada KB, Karathanasis E. Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev. 2014. 30;79-97.

Toy R, Peiris PM, Ghaghada KB, Karathanasis E. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond). 2014 Jan;9(1):121-34.

Toyo-Oka K, Wachi T, Hunt RF, Baraban SC, Taya S, Ramshaw H, Kaibuchi K, Schwarz QP, Lopez AF, Wynshaw-Boris A. 14-3-3‘µ and ‘_ Regulate Neurogenesis and Differentiation of Neuronal Progenitor Cells in the Developing Brain. J Neurosci. 2014 Sep 3;34(36):12168-81. doi: 10.1523/JNEUROSCI.2513-13.2014.

Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia. 2014 Jan;28(1):78-87.

Trotti A, Machtay M. RTOG 9003: Legacies of a Landmark Trial. Int J Radiat Oncol Biol Phys. 2014. 90:253-4.

Tsai YS, Lai CL, Lai CH, Chang KH, Wu K, Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, Sharifi N, Moro L, Tzai TS, Hsieh JT. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth. Oncotarget. 2014 Aug 30;5(15):6425-36.

Tuohy VK. Bench-to-bedside challenges in developing immune protection against breast cancer. Cleve Clin J Med. 2014. 81:605-7.

Tuohy VK. Retired self-proteins as vaccine targets for primary immunoprevention of adult-onset cancers. Expert Rev Vaccines. 2014. 13:1447-62.

Turakhia SK, Hill BT, Dufresne SD, Nakashima MO, Cotta CV. Aggressive B-Cell Lymphomas With Translocations Involving BCL6 and MYC Have Distinct Clinical-Pathologic Characteristics. Am J Clin Pathol. 2014 Sep;142(3):339-46. doi: 10.1309/AJCPBWVHTF7RRSA4.

Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, Dybkaer K, Orazi A, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Ponzoni M, Ferreri AJ, Ye Q, Winter JN, Farnen JP, Piris MA, Møller MB, You MJ, McDonnell T, Medeiros LJ, Young KH. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2014. In press

Uchida N, Hsieh MM, Platner C, Saunthararajah Y, Tisdale JF. Decitabine Suspends Human CD34+ Cell Differentiation and Proliferation during Lentiviral Transduction. PLoS One. 2014;9(8):e104022. doi: 10.1371/journal.pone.0104022.

Ulatowski L, Parker R, Warrier G, Sultana R, Butterfield DA, Manor D. Vitamin E is essential for Purkinje neuron integrity. Neuroscience. 2014 Feb 28;260:120-9.

Valerio M, Stricker PD, Ahmed HU, Dickinson L, Ponsky L, Shnier R, Allen C, Emberton M. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2014 Sep 2. doi: 10.1038/pcan.2014.33. [Epub ahead of print]

Venere M, Hamerlik P, Wu Q, Rasmussen RD, Song LA, Vasanji A, Tenley N, Flavahan WA, Hjelmeland AB, Bartek J, Rich JN. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. Cell Death Differ. 2014 Feb;21(2):258-69. PMCID: PMC3890948

Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT. A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar;83(3):592-6. doi: 10.1016/j.urology.2013.09.075. Review.

Visconte V, Avishai N, Mahfouz R, Tabarroki A, Cowen J, Sharghi-Moshtaghin R, Hitomi M, Rogers HJ, Hasrouni E, Phillips J, Sekeres MA, Heuer AH, Saunthararajah Y, Barnard J, Tiu RV. Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron. Leukemia. 2014 May 23. doi: 10.1038/leu.2014.170. [Epub ahead of print]

Visconte V, Tabarroki A, Gerace CJ, Al-Issa K, Hsi ED, Rogers HJ, Sekeres MA, Silver BJ, Lichtin AE, Mukherjee S, Tiu RV. Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemia. Leuk Lymphoma. 2014. 14:1-3.

Visconte V, Tabarroki A, Zhang L, Hasrouni E, Gerace C, Frum R, Ai J, Advani AS, Duong HK, Kalaycio M, Saunthararajah Y, Sekeres MA, Hsi ED, Shetty S, Rogers HJ, Tiu RV. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10). Am J Hematol. 2014 May 3. doi: 10.1002/ajh.23755. [Epub ahead of print] No abstract available.

Visperas A, Do JS, Bulek K, Li X, Min B. IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice. Mucosal Immunol. 2014 In press

Wabuyele SL, Wald D, Xu Y. Development and validation of LC-MS/MS method for quantitative determination of (-)-securinine in mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:19-26. doi: 10.1016/j.jchromb.2014.04.011. Epub 2014 Apr 13.

Waitkus MS, Chandrasekharan UM, Willard B, Tee TL, Hsieh JK, Przybycin CG, Rini BI, Dicorleto PE. Signal integration and gene induction by a functionally distinct STAT3 phosphoform. Mol Cell Biol. 2014 May;34(10):1800-11. doi: 10.1128/MCB.00034-14. Epub 2014 Mar 10.

Walters MJ, Ebsworth K, Berahovich RD, Penfold ME, Liu SC, Al Omran R, Kioi M, Chernikova SB, Tseng D, Mulkearns-Hubert EE, Sinyuk M, Ransohoff RM, Lathia JD, Karamchandani J, Koort HE, Zhang P, Powers JP, Jaen JC, Schall TJ, Merchant M, Recht L, Brown JM. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. Br J Cancer. 2014 Jan 14. In press

Wan T, Bloch BN, Danish S, Madabhushi A. A Learning Based Fiducial-driven Registration Scheme for Evaluating Laser Ablation Changes in Neurological Disorders. Neurocomputing. 2014. 144:24-37.

Wang H, Han M, Whetsell W Jr, Wang J, Rich J, Hallahan D, Han Z. Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma. Oncogene. 2014 Mar 20;33(12):1558-69. doi: 10.1038/onc.2013.97. Epub 2013 Apr 8.

Wang L, Davidson DD, Montironi R, Lopez-Beltran A, Zhang S, Williamson SR, MacLennan GT, Wang C, Wang M, Emerson RE, Du X, Cheng L. Small cell carcinoma of the prostate: Molecular basis and clinical implications. Histol Histopathol. 2014. in press

Wang SY, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP, Chen J. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival. Breast Cancer Res Treat. 2014. 146:411-9.

Wang X, Huang SS, Heston WD, Guo H, Wang BC, Basilion JP. Development of targeted near-infrared imaging agents for prostate cancer. Mol Cancer Ther. 2014. 13:2595-606.

Wang Y, Roma A, Nolley R, Abdul-Karim F, Peehl DM, Eng C. Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma. Endocr Relat Cancer. 2014. 21):579-86.

Wang Y, Yu Q, He XJ, Romigh T, Altemus J, Eng C. Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation. Mol Cancer Ther. 2014 Jan 28. In press.

Ward MC, Tendulkar RD, Ciezki JP, Klein EA. Future directions from past experience: A century of prostate radiotherapy. Clin Genitourin Cancer. 2014 Feb;12(1):13-20.

Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR. Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biol Blood Marrow Transplant. 2014 Feb;20(2):202-8.

Wechter E, O'Gorman DC, Singh MK, Spanos P, Daly BJ. The effects of an early observational experience on medical students' attitudes toward end-of-life care. Am J Hosp Palliat Care. 2014 In press

Weeks LD, Zentner GE, Scacheri PC, Gerson SL. Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed. Cell Death Dis. 2014 Feb 6;5:e1045.

Weis MC, Avva J, Jacobberger JW, Sreenath SN. A data-driven, mathematical model of mammalian cell cycle regulation. PLoS One. 2014;9(5):e97130. doi: 10.1371/journal.pone.0097130.

Weiss Wiesel TR, Nelson CJ, Tew WP, Hardt M, Mohile SG, Owusu C, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A; The relationship between age, anxiety, and depression in older adults with cancer. Psychooncology. 2014. In Press

Wells BJ, Kattan MW, Cooper GS, Jackson L, Koroukian S. ColoRectal Cancer Predicted Risk Online (CRC-PRO) calculator using data from the multi-ethnic cohort study. J Am Board Fam Med. 2014 Jan-Feb;27(1):42-55.

Wen AM, Steinmetz NF. The Aspect Ratio of Nanoparticle Assemblies and the Spatial Arrangement of Ligands can be Optimized to Enhance the Targeting of Cancer Cells. Adv Healthc Mater. 2014. 3:1739-44.

Wendt MK, Balanis N, Carlin CR, Schiemann WP. STAT3 and epithelial-mesenchymal transitions in carcinomas. JAKSTAT. 2014 Jan 1;3(1):e28975. Epub 2014 Apr 29. Review.

Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Breast Cancer Res. 2014. 16:R24. PMCID: PMC4053226

Werner JJ, Stange KC. Praxis-based Research Networks: An Emerging Paradigm for Research That is Rigorous, Relevant, and Inclusive. J Am Board Fam Med. 2014 . In Press

Wesa AK, Mandic M, Taylor JL, Moschos S, Kirkwood JM, Kwok WW, Finke JH, Storkus WJ. Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients. Front Oncol. 2014. 4:266.

Wildey G, Chen Y, Lent I, Stetson L, Pink J, Barnholtz-Sloan JS, Dowlati A. Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancer. PLoS One. 2014 Sep 8;9(9):e106784. doi: 10.1371/journal.pone.0106784. eCollection 2014.

William BM, de Lima M. Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better? Leuk Lymphoma. 2014 Aug 20:1-2. [Epub ahead of print] No abstract available.

Williams N, Harris LN. The renaissance of endocrine therapy in breast cancer. Curr Opin Obstet Gynecol. 2014 Feb;26(1):41-7.

Wilson RT, Bortner JD Jr, Roff A, Das A, Battaglioli EJ, Richie JP Jr, Barnholtz-Sloan J, Chinchilli VM, Berg A, Liu G, Salzberg AC, El-Bayoumy K. Genetic and environmental influences on plasma vitamin D-binding protein concentrations. Transl Res. 2014. In Press

Woehrer A, Bauchet L, Barnholtz-Sloan JS. Glioblastoma survival: has it improved? Evidence from population-based studies. Curr Opin Neurol. 2014. 27:666-74.

Wong P, Houghton P, Kirsch DG, Finkelstein SE, Monjazeb AM, Xu-Welliver M, Dicker AP, Ahmed M, Vikram B, Teicher BA, Coleman CN, Machtay M, Curran WJ, Wang D. Combining targeted agents with modern radiotherapy in soft tissue sarcomas. J Natl Cancer Inst. 2014. in press

Wood WA, Lee SJ, Brazauskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, Lemaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS. Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2014 Jun;20(6):829-36. doi: 10.1016/j.bbmt.2014.02.021. Epub 2014 Mar 7.

Wright KL, Hamilton JI, Griswold MA, Gulani V, Seiberlich N. Non-Cartesian parallel imaging reconstruction. J Magn Reson Imaging. 2014 Jan 10. DOI: 10.1002/jmri.24521. In press

Wright KL, Harrell MW, Jesberger JA, Landeras L, Nakamoto DA, Thomas S, Nickel D, Kroeker R, Griswold MA, Gulani V. Clinical evaluation of CAIPIRINHA: Comparison against a GRAPPA standard. J Magn Reson Imaging. 2014 Jan;39(1):189-94. PMCID: PMC3865024

Wu C, Qiu S, Lu L, Zou J, Li WF, Wang O, Zhao H, Wang H, Tang J, Chen L, Xu T, Sun Z, Liao W, Luo G, Lu X. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat Commun. 2014 Jan 30;5:3149

Wu H, Wilkins LR, Ziats NP, Haaga JR, Exner AA. Real-time monitoring of radiofrequency ablation and postablation assessment: Accuracy of contrast-enhanced US in experimental rat liver model. Radiology. 2014 Jan;270(1):107-16.

Wu Y, Schomisch SJ, Cipriano C, Chak A, Lash RH, Ponsky JL, Marks JM. Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures. Surg Endosc. 2014 In press

Wyss AB, Weissler MC, Avery CL, Herring AH, Bensen JT, Barnholtz-Sloan JS, Funkhouser WK, Olshan AF. Single nucleotide polymorphisms in nucleotide excision repair genes, cancer treatment, and head and neck cancer survival. Cancer Causes Control. 2014 Feb 2. In press

Xiao W, Hong H, Awadallah A, Zhou L, Xin W. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis. PLoS One. 2014 Jan 29;9(1):e86853.

Xie Q, Flavahan WA, Bao S, Rich J. The tailless root of glioma: cancer stem cells. Cell Stem Cell. 2014 Aug 7;15(2):114-6. doi: 10.1016/j.stem.2014.07.004.

Xu F, Rimm AA, Fu P, Krishnamurthi SS, Cooper GS. The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients. PLoS One. 2014 Sep 19;9(9):e107993. doi:

Xu Y, Guo X, Sun J, Zhao Z. Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation. Bioinformatics. 2014 Sep 5. doi:pii: btu603. [Epub ahead of print]

Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol. 2014. in press

Yan F, Alinari L, Lustberg ME, Martin LK, Cordero-Nieves HM, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell EH, Wojton J, Jacob NK, Chakravarti A, Nowicki MO, Wu X, Lapalombella R, Datta J, Yu B, Gordon K, Haseley A, Patton JT, Smith PL, Ryu J, Zhang X, Mo X, Marcucci G, Nuovo G, Kwon CH, Byrd JC, Chiocca EA, Li C, Sif S, Jacob S, Lawler S, Kaur B, Baiocchi RA. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. Cancer Res. 2014 Jan 22 In press

Yan K, Wu Q, Yan DH, Lee CH, Rahim N, Tritschler I, DeVecchio J, Kalady MF, Hjelmeland AB, Rich JN. Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev. 2014 May 15;28(10):1085-100. doi: 10.1101/gad.235515.113. Epub 2014 May 1.

Yao DC, de Lima M. Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome. Rev Bras Hematol Hemoter. 2014 May-Jun;36(3):173-4. doi: 10.1016/j.bjhh.2014.03.014. Epub 2014 Apr 4. No abstract available.

Yao S, Sucheston LE, Zhao H, Barlow WE, Zirpoli G, Liu S, Moore HC, Budd GT, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB. Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer. Pharmacogenomics J. 2014 In press

Yori JL, Lozada KL, Seachrist DD, Mosley JD, Abdul-Karim FW, Booth CN, Flask CA, Keri RA. Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression. Cancer Res. 2014. 74:4762-71.

Yu W, He X, Ni Y, Ngeow J, Eng C. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation. Hum Mol Genet. 2014 Aug 22. doi:pii: ddu425. [Epub ahead of print]

Yu X, Shahir AM, Sha J, Feng Z, Eapen B, Nithianantham S, Das B, Karn J, Weinberg A, Bissada NF, Ye F. Short chain fatty acids from periodontal pathogens suppress HDACs, EZH2, and SUV39H1 to promote kaposi's sarcoma-associated herpesvirus replication. J Virol. 2014 Feb 5. In press

Zelenskiy S, Thompson CL, Tucker TC, Li L. High dietary glycemic load is associated with increased risk of colon cancer. Nutr Cancer. 2014;66(3):362-8. doi: 10.1080/01635581.2014.884231. Epub 2014 Mar 10.

Zentner GE, Balow SA, Scacheri PC. Genomic characterization of the mouse ribosomal DNA locus. G3 (Bethesda). 2014. In press

Zhang A, Dong B, Doucet AJ, Moldovan JB, Moran JV, Silverman RH. RNase L restricts the mobility of engineered retrotransposons in cultured human cells. Nucleic Acids Res. 2014 Apr;42(6):3803-20. doi: 10.1093/nar/gkt1308. Epub 2013 Dec 25.

Zhang M, Qian J, Lan Y, Lu Y, Li H, Hong B, Zheng Y, He J, Yang J, Yi Q. Anti-β2 M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity. Int J Cancer. 2014. 135:1132-41

Zhang Y, Hunter T. Roles of Chk1 in cell biology and cancer therapy. Int J Cancer. 2014 Mar 1;134(5):1013-23. PMCID: PMC3852170

Zhao S, Sedwick D, Wang Z. Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene. 2014. in press

Zhong B, Lama R, Ketchart W, Montano MM, Su B. Lead optimization of HMBA to develop potent HEXIM1 inducers. Bioorg Med Chem Lett. 2014 Mar 1;24(5):1410-3. doi: 10.1016/j.bmcl.2014.01.025. Epub 2014 Jan 17.

Zhou HL, Luo G, Wise JA, Lou H. Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms. Nucleic Acids Res. 2014 Jan 1;42(2):701-13. PMCID: PMC3902899

Zhou W, Bao S. PML-mediated signaling and its role in cancer stem cells. Oncogene. 2014 Mar 20;33(12):1475-84. doi: 10.1038/onc.2013.111. Epub 2013 Apr 8. Review.

Zhou W, Bao S. Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages. Cancers (Basel). 2014 Mar 26;6(2):723-40. doi: 10.3390/cancers6020723.

Zi FM, He JS, Li Y, Wu C, Wu WJ, Yang Y, Wang LJ, He DH, Yang L, Zhao Y, Zheng GF, Han XY, Huang H, Yi Q, Cai Z. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through B-catenin signaling pathway. Cancer Biol Ther. 2014 Oct 1;15(10):1413-22. doi: 10.4161/cbt.29924. Epub 2014 Jul 21.